##{"id":96535,"date":"2021-09-15T14:18:00","date_gmt":"2021-09-15T04:18:00","guid":{"rendered":"https:\/\/www.fnarena.com\/?p=96535"},"modified":"2021-09-15T14:18:01","modified_gmt":"2021-09-15T04:18:01","slug":"australian-broker-call-extra-edition-sep-15-2021","status":"publish","type":"post","link":"https:\/\/staging.fnarena.com\/index.php\/2021\/09\/15\/australian-broker-call-extra-edition-sep-15-2021\/","title":{"rendered":"Australian Broker Call *Extra* Edition &#8211; Sep 15, 2021"},"content":{"rendered":"<p>FNArena will be updating Special Editions of this Report in September dedicated to the August Reporting Season.<\/p>\n<p><strong>An additional news report on the recommendation, valuation, forecast and opinion changes for ASX-listed&nbsp;equities.<\/strong><\/p>\n<p>In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena&nbsp;has now added The Australian Broker Call *Extra* Edition, featuring additional sources of research and insights on ASX-listed&nbsp;stocks, also enlarging the number of stocks that make up the FNArena&nbsp;universe.<\/p>\n<p>One key difference is the *Extra* Edition will not be updated daily, but merely &quot;regularly&quot; depending on availability&nbsp;of&nbsp;suitable quality content. As such, the *Extra* Edition tries to build a bridge between daily updates via the Australian Broker Call Report and ad hoc news stories, that are not always timely for investors hungry for the next information update.<\/p>\n<p>Investors using the *Extra* Edition as a source of input for their own share market research should thus take into account that information after publication&nbsp;may not be up to date, or yet awaiting another update by FNArena&#039;s&nbsp;team of journalists.<\/p>\n<p>Similar to The Australian Broker Call Report, this *Extra* Edition includes concise but limited reviews of research recently published by Stockbrokers and other experts, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end of this Report.<\/p>\n<p>The Australian Broker Call *Extra* Edition is a summary that has been prepared independently of the sources identified. Readers will check the full text of the recommendations and consult a Licenced Advisor before making any investment decision.<\/p>\n<p>The copyright of this Report is owned by the publisher. Readers will not copy, forward or disseminate this Report to any other person. For more vital information about the sources included, see the bottom of this Report.<\/p>\n<p><strong>COMPANIES DISCUSSED IN THIS ISSUE<\/strong><\/p>\n<p>Click on a symbol for fast access.<br \/>The number next to the symbol represents the number of brokers covering it for this report -(if more than 1)<\/p>\n<p><a href=\"#AIA\" style=\"font-weight:bold\">AIA<\/a>&nbsp;&nbsp; <a href=\"#AMS\" style=\"font-weight:bold\">AMS<\/a>&nbsp;&nbsp; <a href=\"#ARB\" style=\"font-weight:bold\">ARB<\/a>&nbsp;&nbsp; <a href=\"#ASX\" style=\"font-weight:bold\">ASX<\/a>&nbsp;&nbsp; <a href=\"#AVN\" style=\"font-weight:bold\">AVN&nbsp;(2)<\/a>&nbsp;&nbsp; <a href=\"#AX1\" style=\"font-weight:bold\">AX1<\/a>&nbsp;&nbsp; <a href=\"#BLX\" style=\"font-weight:bold\">BLX<\/a>&nbsp;&nbsp; <a href=\"#BOT\" style=\"font-weight:bold\">BOT<\/a>&nbsp;&nbsp; <a href=\"#BRG\" style=\"font-weight:bold\">BRG<\/a>&nbsp;&nbsp; <a href=\"#BXB\" style=\"font-weight:bold\">BXB<\/a>&nbsp;&nbsp; <a href=\"#CL1\" style=\"font-weight:bold\">CL1&nbsp;(2)<\/a>&nbsp;&nbsp; <a href=\"#COH\" style=\"font-weight:bold\">COH<\/a>&nbsp;&nbsp; <a href=\"#CQR\" style=\"font-weight:bold\">CQR<\/a>&nbsp;&nbsp; <a href=\"#CSL\" style=\"font-weight:bold\">CSL<\/a>&nbsp;&nbsp; <a href=\"#CTD\" style=\"font-weight:bold\">CTD<\/a>&nbsp;&nbsp; <a href=\"#DMP\" style=\"font-weight:bold\">DMP&nbsp;(2)<\/a>&nbsp;&nbsp; <a href=\"#DRR\" style=\"font-weight:bold\">DRR<\/a>&nbsp;&nbsp; <a href=\"#EHL\" style=\"font-weight:bold\">EHL&nbsp;(3)<\/a>&nbsp;&nbsp; <a href=\"#EML\" style=\"font-weight:bold\">EML<\/a>&nbsp;&nbsp; <a href=\"#EVS\" style=\"font-weight:bold\">EVS<\/a>&nbsp;&nbsp; <a href=\"#FPH\" style=\"font-weight:bold\">FPH<\/a>&nbsp;&nbsp; <a href=\"#HDN\" style=\"font-weight:bold\">HDN<\/a>&nbsp;&nbsp; <a href=\"#INA\" style=\"font-weight:bold\">INA&nbsp;(2)<\/a>&nbsp;&nbsp; <a href=\"#ING\" style=\"font-weight:bold\">ING<\/a>&nbsp;&nbsp; <a href=\"#IPH\" style=\"font-weight:bold\">IPH&nbsp;(2)<\/a>&nbsp;&nbsp; <a href=\"#IRI\" style=\"font-weight:bold\">IRI<\/a>&nbsp;&nbsp; <a href=\"#LIC\" style=\"font-weight:bold\">LIC&nbsp;(2)<\/a>&nbsp;&nbsp; <a href=\"#MMM\" style=\"font-weight:bold\">MMM<\/a>&nbsp;&nbsp; <a href=\"#MNY\" style=\"font-weight:bold\">MNY<\/a>&nbsp;&nbsp; <a href=\"#NCM\" style=\"font-weight:bold\">NCM<\/a>&nbsp;&nbsp; <a href=\"#NEA\" style=\"font-weight:bold\">NEA<\/a>&nbsp;&nbsp; <a href=\"#NWH\" style=\"font-weight:bold\">NWH&nbsp;(2)<\/a>&nbsp;&nbsp; <a href=\"#NWL\" style=\"font-weight:bold\">NWL<\/a>&nbsp;&nbsp; <a href=\"#OBL\" style=\"font-weight:bold\">OBL<\/a>&nbsp;&nbsp; <a href=\"#OTW\" style=\"font-weight:bold\">OTW<\/a>&nbsp;&nbsp; <a href=\"#OZL\" style=\"font-weight:bold\">OZL&nbsp;(2)<\/a>&nbsp;&nbsp; <a href=\"#PME\" style=\"font-weight:bold\">PME&nbsp;(2)<\/a>&nbsp;&nbsp; <a href=\"#PPT\" style=\"font-weight:bold\">PPT<\/a>&nbsp;&nbsp; <a href=\"#PSQ\" style=\"font-weight:bold\">PSQ<\/a>&nbsp;&nbsp; <a href=\"#SGF\" style=\"font-weight:bold\">SGF<\/a>&nbsp;&nbsp; <a href=\"#SUL\" style=\"font-weight:bold\">SUL<\/a>&nbsp;&nbsp; <a href=\"#SXL\" style=\"font-weight:bold\">SXL<\/a>&nbsp;&nbsp; <a href=\"#SXY\" style=\"font-weight:bold\">SXY&nbsp;(2)<\/a>&nbsp;&nbsp; <a href=\"#TAH\" style=\"font-weight:bold\">TAH<\/a>&nbsp;&nbsp; <a href=\"#TLX\" style=\"font-weight:bold\">TLX<\/a>&nbsp;&nbsp; <a href=\"#TPG\" style=\"font-weight:bold\">TPG<\/a>&nbsp;&nbsp; <a href=\"#VCX\" style=\"font-weight:bold\">VCX<\/a>&nbsp;&nbsp; <a href=\"#WPL\" style=\"font-weight:bold\">WPL<\/a>&nbsp;&nbsp;<\/p>\n<h2><a name=\"AIA\">AIA<\/a>&nbsp;&nbsp;&nbsp; AUCKLAND INTERNATIONAL AIRPORT LIMITED<\/h2>\n<p><strong>Infrastructure &amp; Utilities &#8211; Overnight Price: $7.16 <\/strong><\/p>\n<p>Jarden rates ((AIA)) as Underweight (4) &#8211;<\/p>\n<p>Auckland International Airport&#039;s reported underlying loss of -NZ$41.8m was in line with guidance and Jarden&#039;s forecast. The broker notes results reflect the tough operating environment, with international passengers declining -93% year-on-year and domestic volumes declining -17%.<\/p>\n<p>While the company has not provided an outlook for FY22, it was noted that given current lockdowns&nbsp;total operating expenditure was likely to be at the lower end of the previously guided -NZ$160-175m.&nbsp;<\/p>\n<p>Jarden expects property business to remain the core earnings driver for the next year, with the company expecting to spend NZ$50.5-64.2m in property development in FY22.<\/p>\n<p>The Underweight rating and target price of NZ$6.60 are retained.<\/p>\n<p>This report was published on August 20, 2021.<\/p>\n<p>Current Price is <strong>$7.16<\/strong>. Target price not assessed.<br \/>Current consensus price target is <strong>$6.90<\/strong>, suggesting downside of <strong>-3.6%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Jarden forecasts a full year <strong>FY22<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>0.47<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>1529.91<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>0.6<\/strong>, implying annual growth of <strong>N\/A<\/strong>.<br \/>Current consensus DPS estimate is <strong>0.4<\/strong>, implying a prospective dividend yield of <strong>0.1%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>1193.3<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Jarden forecasts a full year <strong>FY23<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>7.96<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>90.01<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>12.5<\/strong>, implying annual growth of <strong>1983.3%<\/strong>.<br \/>Current consensus DPS estimate is <strong>13.8<\/strong>, implying a prospective dividend yield of <strong>1.9%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>57.3<\/strong>.<\/p>\n<\/blockquote>\n<p>This company reports in <strong>NZD<\/strong>. All estimates have been converted into AUD by FNArena at present FX values.<br \/>Market Sentiment: <strong>0.0<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"AMS\">AMS<\/a>&nbsp;&nbsp;&nbsp; ATOMOS LIMITED<\/h2>\n<p><strong>Consumer Electronics &#8211; Overnight Price: $1.56 <\/strong><\/p>\n<p>Shaw and Partners rates ((AMS)) as Buy (1) &#8211;<\/p>\n<p>Atomos has delivered strong FY21 results, with Shaw and Partners noting record revenue of $78.6m, up 77% on the previous year, gross profit of $37.4m, up 133% on the previous year, and underlying earnings of&nbsp;$8.2m, a $15.4m increase on a negative result in FY21.&nbsp;<\/p>\n<p>The broker highlights results were well ahead of forecast. Further, with the company flagging underlying earnings margins trending towards 12-15%, Shaw upgrades underlying earnings estimates to $12.2m in FY22 (from $10.2m).&nbsp;<\/p>\n<p>The forecast is on the conservative side of Atomos&#039; guidance, and Shaw sees upside risk on new product launches.<\/p>\n<p>The Buy rating is retained and the target price increases to $2.00 from $1.58.&nbsp;<\/p>\n<p>This report was published on August 19, 2021.<\/p>\n<p>Target price is <strong>$2.00<\/strong> Current Price is <strong>$1.56 <\/strong> Difference: <strong>$0.44<\/strong><br \/>If <strong>AMS<\/strong> meets the Shaw and Partners target it will return approximately <strong> 28%<\/strong> (excluding dividends, fees and charges).<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Shaw and Partners forecasts a full year <strong>FY22<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>6.40<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>24.38<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Shaw and Partners forecasts a full year <strong>FY23<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>9.00<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>17.33<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>1.0<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"ARB\">ARB<\/a>&nbsp;&nbsp;&nbsp; ARB CORPORATION LIMITED<\/h2>\n<p><strong>Automobiles &amp; Components &#8211; Overnight Price: $47.58 <\/strong><\/p>\n<p>Wilsons rates ((ARB)) as Overweight (1) &#8211;<\/p>\n<p>ARB Corp&nbsp;has confirmed a strong result for FY21, observes Wilsons, reporting&nbsp;profit before tax growth of 90% on the previous year, and management has confirmed momentum has&nbsp;continued into FY22 with strong global sales.&nbsp;<\/p>\n<p>Wilsons is confident in sustained sales growth driven by new vehicle model releases, continuation of the instant asset write-off scheme, and a broader product range.&nbsp;The broker has increased sales forecasts by 6-7%.<\/p>\n<p>The Overweight rating is retained and the target price increases to $55.00 from $48.40.&nbsp;<\/p>\n<p>This report was published on August 18,&nbsp;2021.<\/p>\n<p>Target price is <strong>$55.00<\/strong> Current Price is <strong>$47.58 <\/strong> Difference: <strong>$7.42<\/strong><br \/>If <strong>ARB<\/strong> meets the Wilsons target it will return approximately <strong> 16%<\/strong> (excluding dividends, fees and charges).<br \/>Current consensus price target is <strong>$46.93<\/strong>, suggesting downside of <strong>-2.5%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Wilsons forecasts a full year <strong>FY22<\/strong> dividend of <strong>69.00<\/strong> cents and EPS of <strong>135.40<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>1.45%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>35.14<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>138.9<\/strong>, implying annual growth of <strong>-0.8%<\/strong>.<br \/>Current consensus DPS estimate is <strong>72.4<\/strong>, implying a prospective dividend yield of <strong>1.5%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>34.7<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Wilsons forecasts a full year <strong>FY23<\/strong> dividend of <strong>69.00<\/strong> cents and EPS of <strong>130.80<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>1.45%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>36.38<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>144.0<\/strong>, implying annual growth of <strong>3.7%<\/strong>.<br \/>Current consensus DPS estimate is <strong>74.8<\/strong>, implying a prospective dividend yield of <strong>1.6%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>33.4<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>-0.3<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"ASX\">ASX<\/a>&nbsp;&nbsp;&nbsp; ASX LIMITED<\/h2>\n<p><strong>Wealth Management &amp; Investments &#8211; Overnight Price: $83.34 <\/strong><\/p>\n<p>Jarden rates ((ASX)) as Underweight (2) &#8211;<\/p>\n<p>ASX&#039;s FY21 profit after tax of $481m was largely in line with estimates, and a 1% beat on Jarden&#039;s&nbsp;forecast, while underlying earnings were 2% ahead of expectations.<\/p>\n<p>Looking ahead, Jarden notes its 4% earnings per share growth outlook for FY22 may fall to&nbsp;1% given risk to Futures volume recovery. Jarden had previously forecast 10% recovery in Futures volumes, but current lockdowns present risk to this assumption.&nbsp;<\/p>\n<p>The broker updates earnings per share guidance by 1.5%, 0.1% and -1.2% through to FY24.&nbsp;The Underweight rating is retained and the target price increases to $76.50 from $74.95.<\/p>\n<p>This report was published on August 19, 2021.&nbsp;<\/p>\n<p>Target price is <strong>$76.50<\/strong> Current Price is <strong>$83.34 <\/strong> Difference: <strong>minus $6.84<\/strong> (current price is over target).<br \/>If <strong>ASX<\/strong> meets the Jarden target it will return approximately <strong>minus 8%<\/strong> (excluding dividends, fees and charges &#8211; negative figures indicate an expected loss).<br \/>Current consensus price target is <strong>$77.41<\/strong>, suggesting downside of <strong>-8.4%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Jarden forecasts a full year <strong>FY22<\/strong> dividend of <strong>233.70<\/strong> cents and EPS of <strong>259.70<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>2.80%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>32.09<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>256.8<\/strong>, implying annual growth of <strong>3.4%<\/strong>.<br \/>Current consensus DPS estimate is <strong>230.3<\/strong>, implying a prospective dividend yield of <strong>2.7%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>32.9<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Jarden forecasts a full year <strong>FY23<\/strong> dividend of <strong>242.30<\/strong> cents and EPS of <strong>269.20<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>2.91%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>30.96<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>264.6<\/strong>, implying annual growth of <strong>3.0%<\/strong>.<br \/>Current consensus DPS estimate is <strong>237.4<\/strong>, implying a prospective dividend yield of <strong>2.8%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>31.9<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>-0.3<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"AVN\">AVN<\/a>&nbsp;&nbsp;&nbsp; AVENTUS GROUP<\/h2>\n<p><strong>REITs &#8211; Overnight Price: $3.36 <\/strong><\/p>\n<p>Goldman Sachs rates ((AVN)) as Buy (1) &#8211;<\/p>\n<p>While Aventus Group has not provided FY22 earnings guidance due to covid uncertainty, Goldman Sachs&#039;&nbsp;positive view remains based on development upside in the group&#039;s&nbsp;portfolio, the operating portfolio&rsquo;s relative strength, and a solid balance sheet with gearing below the target 30-40% range.<\/p>\n<p>Goldman Sachs continues to believe the group is relatively well-positioned in the current environment, given that its large format retail portfolio derives 37% of income from everyday needs tenants and the remainder from homewares, electrical, furniture, bedding, and hardware, all of which the broker expect to continue to perform relatively well.<\/p>\n<p>Buy Rating is maintained and the target price increases to $3.40 from $3.26.<\/p>\n<p>This report was published on August 18, 2021.<\/p>\n<p>Target price is <strong>$3.40<\/strong> Current Price is <strong>$3.36 <\/strong> Difference: <strong>$0.04<\/strong><br \/>If <strong>AVN<\/strong> meets the Goldman Sachs target it will return approximately <strong> 1%<\/strong> (excluding dividends, fees and charges).<br \/>Current consensus price target is <strong>$3.14<\/strong>, suggesting downside of <strong>-6.7%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Goldman Sachs forecasts a full year <strong>FY22<\/strong> dividend of <strong>19.00<\/strong> cents and EPS of <strong>20.00<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>5.65%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>16.80<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>19.4<\/strong>, implying annual growth of <strong>-73.2%<\/strong>.<br \/>Current consensus DPS estimate is <strong>17.6<\/strong>, implying a prospective dividend yield of <strong>5.2%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>17.4<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Goldman Sachs forecasts a full year <strong>FY23<\/strong> EPS of <strong>22.00<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>15.27<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>20.7<\/strong>, implying annual growth of <strong>6.7%<\/strong>.<br \/>Current consensus DPS estimate is <strong>18.6<\/strong>, implying a prospective dividend yield of <strong>5.5%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>16.3<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>0.0<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<hr \/>\n<p>Moelis rates ((AVN)) as Sell (5) &#8211;<\/p>\n<p>Following Aventus Group&#039;s FY21 result, which was in line with revised guidance provided in June, Moelis&nbsp;estimates the group can deliver earnings per share (EPS) growth in FY22, despite pending covid risks, translating to an FY22 distribution per unit (DPU) yield of 5.3%.<\/p>\n<p>Driven by a $297m net valuation uplift with the weighted average credit rating compressing -72bps in FY21, to 6.01%, net tangible assets increased to $2.69 from $2.24 in December 2020.<\/p>\n<p>Moelis notes while ongoing sector tailwinds will remain supportive, and sector cap rates continue firming, the broker views these as being more than priced into the current share price.<\/p>\n<p>Sell rating is maintained, and the target price increases to $2.97 from $2.90<strong>.<\/strong><\/p>\n<p>This report was released on August&nbsp;19, 2021.<\/p>\n<p>Target price is <strong>$2.97<\/strong> Current Price is <strong>$3.36 <\/strong> Difference: <strong>minus $0.39<\/strong> (current price is over target).<br \/>If <strong>AVN<\/strong> meets the Moelis target it will return approximately <strong>minus 12%<\/strong> (excluding dividends, fees and charges &#8211; negative figures indicate an expected loss).<br \/>Current consensus price target is <strong>$3.14<\/strong>, suggesting downside of <strong>-6.7%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Moelis forecasts a full year <strong>FY22<\/strong> dividend of <strong>17.50<\/strong> cents and EPS of <strong>19.30<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>5.21%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>17.41<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>19.4<\/strong>, implying annual growth of <strong>-73.2%<\/strong>.<br \/>Current consensus DPS estimate is <strong>17.6<\/strong>, implying a prospective dividend yield of <strong>5.2%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>17.4<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Moelis forecasts a full year <strong>FY23<\/strong> dividend of <strong>17.80<\/strong> cents and EPS of <strong>20.10<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>5.30%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>16.72<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>20.7<\/strong>, implying annual growth of <strong>6.7%<\/strong>.<br \/>Current consensus DPS estimate is <strong>18.6<\/strong>, implying a prospective dividend yield of <strong>5.5%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>16.3<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>0.0<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"AX1\">AX1<\/a>&nbsp;&nbsp;&nbsp; ACCENT GROUP LIMITED<\/h2>\n<p><strong>Apparel &amp; Footwear &#8211; Overnight Price: $2.05 <\/strong><\/p>\n<p>Bell Potter rates ((AX1)) as Buy (1) &#8211;<\/p>\n<p>While online is providing some cushioning,&nbsp; Accent Group&#039;s trading update for the first 7 weeks of first-half FY22 showed&nbsp;like-for-like sales (including store closures) down -16%, observes Bell Potter.<\/p>\n<p>Lockdowns are expected to slow the rebalance of stock levels, but at the same time, Bell Potter believes having excess inventory is a preferred position ahead of the key December quarter given the underlying global supply chain risks.<\/p>\n<p>The company recently disclosed that it is in process of landlord negotiations&nbsp;to work out the appropriate rent terms during lockdowns, hence containing first half FY22 rent cash outlay to a fair level.<\/p>\n<p>Having&nbsp;cut first-half FY22 estimates to reflect lockdown impacts, the broker&#039;s&nbsp;FY22 earnings estimates fall&nbsp;by -21%, yet&nbsp;there is no material change in FY23\/FY24.<\/p>\n<p>Buy rating is unchanged&nbsp;and the target price is lowered to $2.90 from $3.30.<\/p>\n<p>This report was published&nbsp;on August 20,&nbsp;2021.<\/p>\n<p>Target price is <strong>$2.90<\/strong> Current Price is <strong>$2.05 <\/strong> Difference: <strong>$0.85<\/strong><br \/>If <strong>AX1<\/strong> meets the Bell Potter target it will return approximately <strong> 41%<\/strong> (excluding dividends, fees and charges).<br \/>Current consensus price target is <strong>$2.50<\/strong>, suggesting upside of <strong>8.4%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY22<\/strong> dividend of <strong>9.30<\/strong> cents and EPS of <strong>11.50<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>4.54%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>17.83<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>11.0<\/strong>, implying annual growth of <strong>-22.6%<\/strong>.<br \/>Current consensus DPS estimate is <strong>8.7<\/strong>, implying a prospective dividend yield of <strong>3.8%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>21.0<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY23<\/strong> dividend of <strong>13.30<\/strong> cents and EPS of <strong>16.70<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>6.49%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>12.28<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>15.8<\/strong>, implying annual growth of <strong>43.6%<\/strong>.<br \/>Current consensus DPS estimate is <strong>12.2<\/strong>, implying a prospective dividend yield of <strong>5.3%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>14.6<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>-0.3<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"BLX\">BLX<\/a>&nbsp;&nbsp;&nbsp; BEACON LIGHTING GROUP LIMITED<\/h2>\n<p><strong>Furniture &amp; Renovation &#8211; Overnight Price: $2.05 <\/strong><\/p>\n<p>Jarden rates ((BLX)) as Buy (2) &#8211;<\/p>\n<p>Despite a tough fourth quarter, Beacon Lighting reported a 85%&nbsp;year-on-year profit after tax increase to $37.7m, which Jarden notes was a slight beat on guidance and the broker&#039;s forecast. Group sales also increased 13.3% on the previous year to around $289m.&nbsp;<\/p>\n<p>The broker highlights the strong result despite lockdowns demonstrates&nbsp;the model and management quality. Given ongoing lockdowns, Jarden has lowered FY22 earnings forecast by -6.2%, and expects sales to normalise to pre-covid levels by FY24.<\/p>\n<p>The Overweight rating is retained and the target price decreases to $2.10 from $2.20.<\/p>\n<p>This report was published on August 19, 2021.<\/p>\n<p>Target price is <strong>$2.10<\/strong> Current Price is <strong>$2.05 <\/strong> Difference: <strong>$0.05<\/strong><br \/>If <strong>BLX<\/strong> meets the Jarden target it will return approximately <strong> 2%<\/strong> (excluding dividends, fees and charges).<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Jarden forecasts a full year <strong>FY22<\/strong> dividend of <strong>7.70<\/strong> cents and EPS of <strong>11.70<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>3.76%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>17.52<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Jarden forecasts a full year <strong>FY23<\/strong> dividend of <strong>7.20<\/strong> cents and EPS of <strong>10.90<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>3.51%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>18.81<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>1.0<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"BOT\">BOT<\/a>&nbsp;&nbsp;&nbsp; BOTANIX PHARMACEUTICALS LIMITED<\/h2>\n<p><strong>Pharmaceuticals &amp; Biotech\/Lifesciences &#8211; Overnight Price: $0.07 <\/strong><\/p>\n<p>Euroz Hartleys rates ((BOT)) as Speculative Buy (2) &#8211;<\/p>\n<p>Euroz Hartleys is initiating coverage of Botanix Pharmaceuticals Ltd with a Speculative Buy recommendation and a target price of $0.17.<\/p>\n<p>Botanix Pharmaceuticals is a clinical stage synthetic cannabinoid pharmaceutical company which the broker believes is planning to make its mark in major global markets in dermatology and antimicrobials with&nbsp;four individual clinical programs.<\/p>\n<p>Assuming the individual programs are ultimately clinically successful, the broker expects the potential upside for the company is&nbsp;huge.<\/p>\n<p>While&nbsp;Euroz Hartleys suspects&nbsp;the market is pricing in unsuccessful outcomes, the broker&#039;s initial assessment into the company&rsquo;s programs and&nbsp;clinical studies suggests otherwise.<\/p>\n<p>With an enterprise value&nbsp;of $50m, the broker argues there is a very promising&nbsp;risk-to-reward case.<\/p>\n<p>Target price is <strong>$0.17<\/strong> Current Price is <strong>$0.07 <\/strong> Difference: <strong>$0.1<\/strong><br \/>If <strong>BOT<\/strong> meets the Euroz Hartleys target it will return approximately <strong> 143%<\/strong> (excluding dividends, fees and charges).<\/p>\n<p>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"BRG\">BRG<\/a>&nbsp;&nbsp;&nbsp; BREVILLE GROUP LIMITED<\/h2>\n<p><strong>Household &amp; Personal Products &#8211; Overnight Price: $29.29 <\/strong><\/p>\n<p>Wilsons rates ((BRG)) as Market Weight (3) &#8211;<\/p>\n<p>Breville Group reported underlying earnings of $136.4m for FY21, a 20.5% year-on-year increase. Wilsons notes the result is despite a -$31.3m increase in marketing costs.<\/p>\n<p>While no quantitative guidance has been provided, Wilsons notes the company has pointed to FY22 being a transition year. The broker further highlighted&nbsp;considerable risks exist for material supply, input costs and freight charges in the first half of FY22.<\/p>\n<p>The Market Weight rating is retained and the target price decreases to $26.69 from $32.00.<\/p>\n<p>This&nbsp;report was published on August 18, 2021.&nbsp;<\/p>\n<p>Target price is <strong>$26.69<\/strong> Current Price is <strong>$29.29 <\/strong> Difference: <strong>minus $2.6<\/strong> (current price is over target).<br \/>If <strong>BRG<\/strong> meets the Wilsons target it will return approximately <strong>minus 9%<\/strong> (excluding dividends, fees and charges &#8211; negative figures indicate an expected loss).<br \/>Current consensus price target is <strong>$33.59<\/strong>, suggesting upside of <strong>10.8%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Wilsons forecasts a full year <strong>FY22<\/strong> dividend of <strong>31.50<\/strong> cents and EPS of <strong>73.30<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>1.08%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>39.96<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>76.6<\/strong>, implying annual growth of <strong>16.5%<\/strong>.<br \/>Current consensus DPS estimate is <strong>31.0<\/strong>, implying a prospective dividend yield of <strong>1.0%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>39.6<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Wilsons forecasts a full year <strong>FY23<\/strong> dividend of <strong>37.00<\/strong> cents and EPS of <strong>85.50<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>1.26%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>34.26<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>87.9<\/strong>, implying annual growth of <strong>14.8%<\/strong>.<br \/>Current consensus DPS estimate is <strong>35.4<\/strong>, implying a prospective dividend yield of <strong>1.2%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>34.5<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>0.7<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"BXB\">BXB<\/a>&nbsp;&nbsp;&nbsp; BRAMBLES LIMITED<\/h2>\n<p><strong>Transportation &amp; Logistics &#8211; Overnight Price: $11.24 <\/strong><\/p>\n<p>Jarden rates ((BXB)) as Buy (2) &#8211;<\/p>\n<p>Brambles has reported underlying earnings of US$879m for FY21, against a backdrop of strong revenue growth.&nbsp;<\/p>\n<p>Jarden particularly noted Brambles was able to meet guidance to increase US Pallets&#039; underlying earnings margins by 100 basis points, despite cost inflation and an increase in IPEP charges, the majority of which came from a -$60m increase in surcharges.<\/p>\n<p>Given expected higher capital expenditure, including -$180m in deferred capital expenditure now set to be added to FY22 results, as well as higher depreciation and amortisation in the next year, Jarden&#039;s earnings per share forecasts remain largely unchanged despite an increase in top-line forecasts.<\/p>\n<p>The broker awaits a clearer outlook following the company&#039;s strategy day in September.&nbsp;The Overweight rating is retained and the target price increases to $12.75 from $11.85.&nbsp;<\/p>\n<p>This report was published on August 18, 2021.<\/p>\n<p>Target price is <strong>$12.75<\/strong> Current Price is <strong>$11.24 <\/strong> Difference: <strong>$1.51<\/strong><br \/>If <strong>BXB<\/strong> meets the Jarden target it will return approximately <strong> 13%<\/strong> (excluding dividends, fees and charges).<br \/>Current consensus price target is <strong>$12.75<\/strong>, suggesting upside of <strong>16.3%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Jarden forecasts a full year <strong>FY22<\/strong> dividend of <strong>31.66<\/strong> cents and EPS of <strong>52.94<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>2.82%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>21.23<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>56.1<\/strong>, implying annual growth of <strong>N\/A<\/strong>.<br \/>Current consensus DPS estimate is <strong>34.0<\/strong>, implying a prospective dividend yield of <strong>3.1%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>19.5<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Jarden forecasts a full year <strong>FY23<\/strong> dividend of <strong>35.52<\/strong> cents and EPS of <strong>54.67<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>3.16%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>20.56<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>61.2<\/strong>, implying annual growth of <strong>9.1%<\/strong>.<br \/>Current consensus DPS estimate is <strong>37.5<\/strong>, implying a prospective dividend yield of <strong>3.4%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>17.9<\/strong>.<\/p>\n<\/blockquote>\n<p>This company reports in <strong>USD<\/strong>. All estimates have been converted into AUD by FNArena at present FX values.<br \/>Market Sentiment: <strong>0.5<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"CL1\">CL1<\/a>&nbsp;&nbsp;&nbsp; CLASS LIMITED<\/h2>\n<p><strong>Cloud services &#8211; Overnight Price: $1.82 <\/strong><\/p>\n<p>Jarden rates ((CL1)) as Buy (1) &#8211;<\/p>\n<p>Jarden notes Class&#039; FY22 outlook is solid, with the company guiding to revenue of $65m, an 18% year-on-year increase, and underlying earnings of $25m.<\/p>\n<p>Class has announced the acquisition of legal documents software provider Topdocs for $13m, expected to accelerate document management customer growth by 28%.&nbsp;<\/p>\n<p>Reflecting the impact of Class&#039; newest acquisition, Jarden updates revenue forecasts 5% and 4% for FY22 and FY23 respectively.<\/p>\n<p>The Buy rating and target price of $2.58 are retained.<\/p>\n<p>This report was published on August 17, 2021.<\/p>\n<p>Target price is <strong>$2.58<\/strong> Current Price is <strong>$1.82 <\/strong> Difference: <strong>$0.76<\/strong><br \/>If <strong>CL1<\/strong> meets the Jarden target it will return approximately <strong> 42%<\/strong> (excluding dividends, fees and charges).<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Jarden forecasts a full year <strong>FY22<\/strong> dividend of <strong>5.00<\/strong> cents and EPS of <strong>6.30<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>2.75%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>28.89<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Jarden forecasts a full year <strong>FY23<\/strong> dividend of <strong>6.00<\/strong> cents and EPS of <strong>7.50<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>3.30%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>24.27<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>1.0<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<hr \/>\n<p>Wilsons rates ((CL1)) as Upgrade to Overweight from Market Weight (1) &#8211;<\/p>\n<p>Class&#039; FY21 results were largely in line with Wilsons&#039; expectations, with revenue up 15% and underlying earnings up 16% on FY20 results.<\/p>\n<p>The company also announced its fourth acquisition in 18 months, which the broker notes will continue to accelerate top-line growth. Class has acquired&nbsp;TopDocs for -$13m, expected to close in September 2021.&nbsp;<\/p>\n<p>Looking ahead, Class is guiding to 18% revenue growth in FY22, comprised of 13% organic growth and 4% acquisitive growth.&nbsp;<\/p>\n<p>The rating is upgraded to Overweight from Market Weight and the target price increases to $2.31 from $2.26.&nbsp;<\/p>\n<p>This report was published on August 18, 2021.<\/p>\n<p>Target price is <strong>$2.31<\/strong> Current Price is <strong>$1.82 <\/strong> Difference: <strong>$0.49<\/strong><br \/>If <strong>CL1<\/strong> meets the Wilsons target it will return approximately <strong> 27%<\/strong> (excluding dividends, fees and charges).<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Wilsons forecasts a full year <strong>FY22<\/strong> dividend of <strong>2.40<\/strong> cents and EPS of <strong>5.50<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>1.32%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>33.09<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Wilsons forecasts a full year <strong>FY23<\/strong> dividend of <strong>2.40<\/strong> cents and EPS of <strong>6.60<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>1.32%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>27.58<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>1.0<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"COH\">COH<\/a>&nbsp;&nbsp;&nbsp; COCHLEAR LIMITED<\/h2>\n<p><strong>Medical Equipment &amp; Devices &#8211; Overnight Price: $230.00 <\/strong><\/p>\n<p>Wilsons rates ((COH)) as Market Weight (3) &#8211;<\/p>\n<p>Overall, Cochlear&#039;s volumes have recovered with cochlear&nbsp;implants around 10% up on&nbsp;pre-covid levels while&nbsp;the mix (paediatrics\/adults) has&nbsp;restored to norms, Wilsons observes.<\/p>\n<p>Wilsons also notes that while Europe remains sluggish, emerging market activity resumed in the second half, while OSIA 2 adoption was stronger than the broker expected.<\/p>\n<p>FY22 net profit guidance is in line with FY19, which Wilsons suspects will deliver flat to mid-single-digit revenue growth this year.<\/p>\n<p>The&nbsp;broker has not made any material changes to&nbsp;forecasts at this stage, but notes&nbsp;the conservative outlook is laden with covid caveats.<\/p>\n<p>Market Weight rating and $230 target maintained.<\/p>\n<p>This report was released on August 20, 2021.<\/p>\n<p>Target price is <strong>$230.00<\/strong> Current Price is <strong>$230.00 <\/strong> Difference: <strong>$0<\/strong><br \/>If <strong>COH<\/strong> meets the Wilsons target it will return approximately <strong> 0%<\/strong> (excluding dividends, fees and charges).<br \/>Current consensus price target is <strong>$222.64<\/strong>, suggesting downside of <strong>-5.4%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Current consensus EPS estimate is <strong>421.5<\/strong>, implying annual growth of <strong>-15.1%<\/strong>.<br \/>Current consensus DPS estimate is <strong>312.3<\/strong>, implying a prospective dividend yield of <strong>1.3%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>55.8<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Current consensus EPS estimate is <strong>494.2<\/strong>, implying annual growth of <strong>17.2%<\/strong>.<br \/>Current consensus DPS estimate is <strong>379.9<\/strong>, implying a prospective dividend yield of <strong>1.6%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>47.6<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>-0.1<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"CQR\">CQR<\/a>&nbsp;&nbsp;&nbsp; CHARTER HALL RETAIL REIT<\/h2>\n<p><strong>REITs &#8211; Overnight Price: $3.92 <\/strong><\/p>\n<p>Jarden rates ((CQR)) as Buy (2) &#8211;<\/p>\n<p>Wilsons notes that while Charter Hall Retail REIT will be impacted by ongoing lockdowns in FY22, the company has historically been less affected than competitors.<\/p>\n<p>The broker is forecasting a -$8m rent loss in the first half of FY22 and a quick recovery once restrictions are lifted.&nbsp;<\/p>\n<p>The broker also highlighted&nbsp;the company looks set to build on the acquisitive&nbsp;momentum of last year, having started FY22 with the $51.2m acquisition of Butler Central. Wilson assumes the company will add a further $100m in acquisitions per year.<\/p>\n<p>The Overweight rating is retained and the target price increases to $4.30 from $4.20.<\/p>\n<p>This report was first issue on August 17, 2021.<\/p>\n<p>Target price is <strong>$4.30<\/strong> Current Price is <strong>$3.92 <\/strong> Difference: <strong>$0.38<\/strong><br \/>If <strong>CQR<\/strong> meets the Jarden target it will return approximately <strong> 10%<\/strong> (excluding dividends, fees and charges).<br \/>Current consensus price target is <strong>$3.80<\/strong>, suggesting downside of <strong>-3.4%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Jarden forecasts a full year <strong>FY22<\/strong> dividend of <strong>23.70<\/strong> cents and EPS of <strong>27.90<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>6.05%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>14.05<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>27.3<\/strong>, implying annual growth of <strong>-46.4%<\/strong>.<br \/>Current consensus DPS estimate is <strong>24.5<\/strong>, implying a prospective dividend yield of <strong>6.2%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>14.4<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Jarden forecasts a full year <strong>FY23<\/strong> dividend of <strong>26.30<\/strong> cents and EPS of <strong>29.20<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>6.71%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>13.42<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>28.5<\/strong>, implying annual growth of <strong>4.4%<\/strong>.<br \/>Current consensus DPS estimate is <strong>25.9<\/strong>, implying a prospective dividend yield of <strong>6.6%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>13.8<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>0.3<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"CSL\">CSL<\/a>&nbsp;&nbsp;&nbsp; CSL LIMITED<\/h2>\n<p><strong>Pharmaceuticals &amp; Biotech\/Lifesciences &#8211; Overnight Price: $300.68 <\/strong><\/p>\n<p>Goldman Sachs rates ((CSL)) as Neutral (3) &#8211;<\/p>\n<p>Goldman Sachs notes while there are many reasons to like CSL, the current enterprise valuation, 21% above the 5-year average, does not appear to reflect&nbsp;supply\/cost uncertainties that remain more elevated than the broker had expected to see at this stage.<\/p>\n<p>Goldman Sachs has revised FY22 forecasts to reflect a softer margin development (-4%). While Goldman Sachs posts a modest upgrade to FY23 (1%), the broker&nbsp;still forecasts -6% below consensus.<\/p>\n<p>Goldman Sachs retains its Neutral rating with the target price increasing to $305 from $302.<\/p>\n<p>This report was published on August 18, 20201.<\/p>\n<p>Target price is <strong>$305.00<\/strong> Current Price is <strong>$300.68 <\/strong> Difference: <strong>$4.32<\/strong><br \/>If <strong>CSL<\/strong> meets the Goldman Sachs target it will return approximately <strong> 1%<\/strong> (excluding dividends, fees and charges).<br \/>Current consensus price target is <strong>$308.84<\/strong>, suggesting upside of <strong>1.3%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Goldman Sachs forecasts a full year <strong>FY22<\/strong> dividend of <strong>283.32<\/strong> cents and EPS of <strong>665.07<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>0.94%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>45.21<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>666.3<\/strong>, implying annual growth of <strong>N\/A<\/strong>.<br \/>Current consensus DPS estimate is <strong>309.2<\/strong>, implying a prospective dividend yield of <strong>1.0%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>45.8<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Goldman Sachs forecasts a full year <strong>FY23<\/strong> dividend of <strong>332.54<\/strong> cents and EPS of <strong>763.50<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>1.11%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>39.38<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>802.1<\/strong>, implying annual growth of <strong>20.4%<\/strong>.<br \/>Current consensus DPS estimate is <strong>351.9<\/strong>, implying a prospective dividend yield of <strong>1.2%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>38.0<\/strong>.<\/p>\n<\/blockquote>\n<p>This company reports in <strong>USD<\/strong>. All estimates have been converted into AUD by FNArena at present FX values.<br \/>Market Sentiment: <strong>0.3<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"CTD\">CTD<\/a>&nbsp;&nbsp;&nbsp; CORPORATE TRAVEL MANAGEMENT LIMITED<\/h2>\n<p><strong>Travel, Leisure &amp; Tourism &#8211; Overnight Price: $21.76 <\/strong><\/p>\n<p>Bell Potter rates ((CTD)) as Buy (1) &#8211;<\/p>\n<p>Corporate Travel has reported a final FY21 underlying earnings loss of -$7.2, which, while down on the previous corresponding period, was a $6.5m beat on Bell Potter&#039;s forecast. Similarly, profit after tax was down year-on-year to -$31.0m (loss).<\/p>\n<p>Despite this, Bell Potter notes Corporate Travel Management performed well ahead of listed peers throughout covid-19, and reported a strong fourth quarter result.<\/p>\n<p>While the company is yet to provide FY22 guidance, dividends are expected to return. Following the FY21 results, Bell Potter has updated FY22 earnings per share forecasts by -1.2%, -0.3% and 5.4% through to FY24.&nbsp;<\/p>\n<p>The Buy rating is retained and the target price increases to $24.00 from $22.60.<\/p>\n<p>The report was published on August 19, 2021.<\/p>\n<p>Target price is <strong>$24.00<\/strong> Current Price is <strong>$21.76 <\/strong> Difference: <strong>$2.24<\/strong><br \/>If <strong>CTD<\/strong> meets the Bell Potter target it will return approximately <strong> 10%<\/strong> (excluding dividends, fees and charges).<br \/>Current consensus price target is <strong>$23.65<\/strong>, suggesting upside of <strong>12.2%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY22<\/strong> dividend of <strong>15.00<\/strong> cents and EPS of <strong>34.00<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>0.69%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>64.00<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>44.7<\/strong>, implying annual growth of <strong>N\/A<\/strong>.<br \/>Current consensus DPS estimate is <strong>15.2<\/strong>, implying a prospective dividend yield of <strong>0.7%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>47.2<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY23<\/strong> dividend of <strong>28.00<\/strong> cents and EPS of <strong>76.80<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>1.29%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>28.33<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>95.7<\/strong>, implying annual growth of <strong>114.1%<\/strong>.<br \/>Current consensus DPS estimate is <strong>42.7<\/strong>, implying a prospective dividend yield of <strong>2.0%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>22.0<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>0.7<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"DMP\">DMP<\/a>&nbsp;&nbsp;&nbsp; DOMINO&#039;S PIZZA ENTERPRISES LIMITED<\/h2>\n<p><strong>Food, Beverages &amp; Tobacco &#8211; Overnight Price: $164.98 <\/strong><\/p>\n<p>Bell Potter rates ((DMP)) as Buy (1) &#8211;<\/p>\n<p>Domino&#039;s Pizza Enterprises has reported solid FY21 results, with&nbsp;profit after tax of $188.2m, a 29.2% year-on-year increase. Network sales increased 14.6% and same store sales were up 9.3%.<\/p>\n<p>Bell Potter notes the Japan sector was the highlight of results, with underlying earnings up 52.8% year-on-year, same store sales up 21.8% and 126 new store adds.<\/p>\n<p>The broker also highlights positive momentum has continued into FY22. The company has increased new store opening pace and is now guiding to 9-12% new store openings in the next 3-5 years.&nbsp;<\/p>\n<p>The Buy rating is retained and the target price increases to $155.00 from $132.00.<\/p>\n<p>This report was published&nbsp;on August 19,&nbsp;2021.<\/p>\n<p>Target price is <strong>$155.00<\/strong> Current Price is <strong>$164.98 <\/strong> Difference: <strong>minus $9.98<\/strong> (current price is over target).<br \/>If <strong>DMP<\/strong> meets the Bell Potter target it will return approximately <strong>minus 6%<\/strong> (excluding dividends, fees and charges &#8211; negative figures indicate an expected loss).<br \/>Current consensus price target is <strong>$116.07<\/strong>, suggesting downside of <strong>-29.8%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY22<\/strong> dividend of <strong>203.30<\/strong> cents and EPS of <strong>254.20<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>1.23%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>64.90<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>254.2<\/strong>, implying annual growth of <strong>19.5%<\/strong>.<br \/>Current consensus DPS estimate is <strong>186.7<\/strong>, implying a prospective dividend yield of <strong>1.1%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>65.0<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY23<\/strong> dividend of <strong>248.20<\/strong> cents and EPS of <strong>310.20<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>1.50%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>53.19<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>303.1<\/strong>, implying annual growth of <strong>19.2%<\/strong>.<br \/>Current consensus DPS estimate is <strong>232.5<\/strong>, implying a prospective dividend yield of <strong>1.4%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>54.5<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>-0.2<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<hr \/>\n<p>Goldman Sachs rates ((DMP)) as Buy (1) &#8211;<\/p>\n<p>Apart from the strong topline performance, Goldman Sachs believes the revised growth outlook was a major positive from Domino&#039;s Pizza&#039;s&nbsp;FY21 result, with store growth targets increasing by circa 20% including Taiwan, and&nbsp;with rollout momentum in Europe and Japan expected to remain at record levels.<\/p>\n<p>Management also provided medium-term milestones of around 4000 stores in 2023 and 5000 stores in 2026-27 which to the broker implies an exceptionally strong rollout in the near term.<\/p>\n<p>Overall, Goldman Sachs revises earnings forecasts by around 3.4% and 3.7% respectively in FY22 and FY23 but notes more significantly in the medium term reflecting the improved pipeline.<\/p>\n<p>The broker maintains its Buy rating and the target price increases to $154.90 from $121.40.<\/p>\n<p>This report was published on August 19, 2021.<\/p>\n<p>Target price is <strong>$154.90<\/strong> Current Price is <strong>$164.98 <\/strong> Difference: <strong>minus $10.08<\/strong> (current price is over target).<br \/>If <strong>DMP<\/strong> meets the Goldman Sachs target it will return approximately <strong>minus 6%<\/strong> (excluding dividends, fees and charges &#8211; negative figures indicate an expected loss).<br \/>Current consensus price target is <strong>$116.07<\/strong>, suggesting downside of <strong>-29.8%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Goldman Sachs forecasts a full year <strong>FY22<\/strong> dividend of <strong>222.00<\/strong> cents and EPS of <strong>277.00<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>1.35%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>59.56<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>254.2<\/strong>, implying annual growth of <strong>19.5%<\/strong>.<br \/>Current consensus DPS estimate is <strong>186.7<\/strong>, implying a prospective dividend yield of <strong>1.1%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>65.0<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Goldman Sachs forecasts a full year <strong>FY23<\/strong> dividend of <strong>265.00<\/strong> cents and EPS of <strong>332.00<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>1.61%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>49.69<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>303.1<\/strong>, implying annual growth of <strong>19.2%<\/strong>.<br \/>Current consensus DPS estimate is <strong>232.5<\/strong>, implying a prospective dividend yield of <strong>1.4%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>54.5<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>-0.2<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"DRR\">DRR<\/a>&nbsp;&nbsp;&nbsp; DETERRA ROYALTIES LIMITED<\/h2>\n<p><strong>Iron Ore &#8211; Overnight Price: $3.91 <\/strong><\/p>\n<p>Shaw and Partners rates ((DRR)) as Initiation of coverage with Hold (3) &#8211;<\/p>\n<p>Shaw and Partners notes the highlight of Deterra Royalties FY21 was the successful demerger from Iluka Resources&nbsp;((ILU)), offering a operating and&nbsp;capital expenditure free mining option to Australian investors.<\/p>\n<p>Deterra Royalties&#039; inaugural financial year results showed $145.2m in revenue and $94.3m profit after tax, both in line with consensus forecasts.&nbsp;The company also delivered a 13.97 cents per share full year dividend, which Shaw and Partners notes represents eight months of royalties income.&nbsp;<\/p>\n<p>It is Shaw and Partners&#039; view that Deterra Royalties represents the most significant iron ore growth profile, but consensus iron ore price forecasts offset most top line growth by 2025.&nbsp;<\/p>\n<p>The broker is Hold rated with a target price of $4.30.<\/p>\n<p>This report was published on August 19, 2021.<\/p>\n<p>Target price is <strong>$4.30<\/strong> Current Price is <strong>$3.91 <\/strong> Difference: <strong>$0.39<\/strong><br \/>If <strong>DRR<\/strong> meets the Shaw and Partners target it will return approximately <strong> 10%<\/strong> (excluding dividends, fees and charges).<br \/>Current consensus price target is <strong>$4.97<\/strong>, suggesting upside of <strong>27.8%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Shaw and Partners forecasts a full year <strong>FY22<\/strong> dividend of <strong>27.00<\/strong> cents and EPS of <strong>27.20<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>6.91%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>14.38<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>28.7<\/strong>, implying annual growth of <strong>60.9%<\/strong>.<br \/>Current consensus DPS estimate is <strong>28.3<\/strong>, implying a prospective dividend yield of <strong>7.3%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>13.6<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Shaw and Partners forecasts a full year <strong>FY23<\/strong> dividend of <strong>27.00<\/strong> cents and EPS of <strong>27.90<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>6.91%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>14.01<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>27.4<\/strong>, implying annual growth of <strong>-4.5%<\/strong>.<br \/>Current consensus DPS estimate is <strong>28.5<\/strong>, implying a prospective dividend yield of <strong>7.3%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>14.2<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>0.8<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"EHL\">EHL<\/a>&nbsp;&nbsp;&nbsp; EMECO HOLDINGS LIMITED<\/h2>\n<p><strong>Mining Sector Contracting &#8211; Overnight Price: $1.15 <\/strong><\/p>\n<p>Bell Potter rates ((EHL)) as Buy (1) &#8211;<\/p>\n<p>Following Emeco Holdings&#039; &quot;mixed&quot; FY21 result, Bell Potter believes resilient east coast coal markets and underlying strength in gold and iron ore contribute to the strong expectation of improving utilisation across FY22.<\/p>\n<p>The broker&#039;s updated outlook&nbsp;results in minor revisions to underlying earnings per share (EPS) estimates for FY22&nbsp;and FY23&nbsp;respectively.<\/p>\n<p>Bell Potter has&nbsp;also revised cash flow for the higher sustaining capex expectations, plus -$10-15m of growth capex for Pit N Portal.<\/p>\n<p>The broker&nbsp;believes the company&#039;s robust&nbsp;balance sheet, heightened free cash flow&nbsp;profile, underutilised asset base, and mixed commodity exposure is undervalued at market prices.<\/p>\n<p>The Buy rating and the target price of $1.55 are&nbsp;retained.<\/p>\n<p>This report was published on August 20, 2021.<\/p>\n<p>Target price is <strong>$1.55<\/strong> Current Price is <strong>$1.15 <\/strong> Difference: <strong>$0.4<\/strong><br \/>If <strong>EHL<\/strong> meets the Bell Potter target it will return approximately <strong> 35%<\/strong> (excluding dividends, fees and charges).<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY22<\/strong> dividend of <strong>4.70<\/strong> cents and EPS of <strong>14.70<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>4.09%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>7.82<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY23<\/strong> dividend of <strong>5.30<\/strong> cents and EPS of <strong>16.60<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>4.61%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>6.93<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>1.0<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<hr \/>\n<p>Canaccord Genuity rates ((EHL)) as Buy (1) &#8211;<\/p>\n<p>Emeco Holdings&nbsp;delivered headline earnings at the top end of the recently provided guidance and has&nbsp;flagged that 25%-40% of earnings would be used in capital management.<\/p>\n<p>The company announced a 1.25c dividend, plus&nbsp;a $4m buyback.<\/p>\n<p>Segmentally, Canaccord Genuity notes the commentary was bullish for all groups with some second-half FY22 weighting in rental and Pit N Portal. The utilisation commentary on the call indicated positive momentum heading into FY23, with the suggestion of potential for high 60&#039;s in FY23 compared to the broker&#039;s&nbsp;current assumption of 63.5%.<\/p>\n<p>The broker has increased&nbsp;capex assumptions slightly based on the result commentary, with group&nbsp;earnings estimates increasing by 4% and 5% for FY22 and FY23 respectively.<\/p>\n<p>Buy rating is unchanged and the target price increases to $1.51 from $1.44.<\/p>\n<p>This report was published on August 19, 2021.<\/p>\n<p>Target price is <strong>$1.51<\/strong> Current Price is <strong>$1.15 <\/strong> Difference: <strong>$0.36<\/strong><br \/>If <strong>EHL<\/strong> meets the Canaccord Genuity target it will return approximately <strong> 31%<\/strong> (excluding dividends, fees and charges).<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Canaccord Genuity forecasts a full year <strong>FY22<\/strong> dividend of <strong>4.10<\/strong> cents and EPS of <strong>13.70<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>3.57%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>8.39<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Canaccord Genuity forecasts a full year <strong>FY23<\/strong> dividend of <strong>4.60<\/strong> cents and EPS of <strong>15.20<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>4.00%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>7.57<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>1.0<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<hr \/>\n<p>Moelis rates ((EHL)) as Buy (1) &#8211;<\/p>\n<p>Following Emeco Holdings&rsquo;&nbsp;FY21 earnings of $238m, at top end of guidance and in line, the company noted that while no quantitative guidance&nbsp;was provided&nbsp;it was comfortable with current consensus FY22 operating earnings&nbsp;($262m).<\/p>\n<p>Moelis&#039; favourable investment view is based on commodity price strength which supports a growth outlook and utilisation recovery.&nbsp;<\/p>\n<p>Moelis notes while gold is now the company&#039;s largest exposure at 37% FY21 revenue, the eastern region comprises 70-80% of rental earnings and historically had strong leverage to coal prices.<\/p>\n<p>The broker believes the recent strong recovery in coal prices could be a potential driver of utilisation recovery and earnings growth.<\/p>\n<p>With the company trading on a 6.8x enterprise multiple, a -25% discount to its peer average of 9.0x, Moelis believes the company&#039;s&nbsp;valuation remains attractive.<\/p>\n<p>Moelis maintains the Buy rating and the target increases to $1.81 from $1.50.<\/p>\n<p>This report was published on August 18, 2021.<\/p>\n<p>Target price is <strong>$1.81<\/strong> Current Price is <strong>$1.15 <\/strong> Difference: <strong>$0.66<\/strong><br \/>If <strong>EHL<\/strong> meets the Moelis target it will return approximately <strong> 57%<\/strong> (excluding dividends, fees and charges).<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Moelis forecasts a full year <strong>FY22<\/strong> dividend of <strong>5.00<\/strong> cents and EPS of <strong>14.50<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>4.35%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>7.93<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Moelis forecasts a full year <strong>FY23<\/strong> dividend of <strong>5.00<\/strong> cents and EPS of <strong>16.10<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>4.35%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>7.14<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>1.0<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"EML\">EML<\/a>&nbsp;&nbsp;&nbsp; EML PAYMENTS LIMITED<\/h2>\n<p><strong>Business &amp; Consumer Credit &#8211; Overnight Price: $3.85 <\/strong><\/p>\n<p>Wilsons rates ((EML)) as Overweight (1) &#8211;<\/p>\n<p>With EML Payments having delivered a FY21 result, which Wilsons described as comprehensive, the broker thinks it is time for the market to look past the PFS Card Services regulatory issues and towards a bigger picture.<\/p>\n<p>Wilsons notes EML Payments has&nbsp;incurred -$11.5m in one-off payments and ongoing fees in response to Central Bank concerns, and impact has been limited so far.<\/p>\n<p>Looking ahead, the company is guiding to a 22% revenue increase, a 15% underlying earnings increase and a -6% net profit after tax decrease in FY22. Wilsons has updated FY22 forecasts to reflect guidance.<\/p>\n<p>The Overweight rating is retained and the target price increases to $4.71 from $4.14.<\/p>\n<p>This report was released on August 18, 2021.<\/p>\n<p>Target price is <strong>$4.71<\/strong> Current Price is <strong>$3.85 <\/strong> Difference: <strong>$0.86<\/strong><br \/>If <strong>EML<\/strong> meets the Wilsons target it will return approximately <strong> 22%<\/strong> (excluding dividends, fees and charges).<br \/>Current consensus price target is <strong>$4.58<\/strong>, suggesting upside of <strong>18.3%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Wilsons forecasts a full year <strong>FY22<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>8.80<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>43.75<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>5.8<\/strong>, implying annual growth of <strong>N\/A<\/strong>.<br \/>Current consensus DPS estimate is <strong>N\/A<\/strong>, implying a prospective dividend yield of <strong>N\/A<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>66.7<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Wilsons forecasts a full year <strong>FY23<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>13.90<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>27.70<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>11.8<\/strong>, implying annual growth of <strong>103.4%<\/strong>.<br \/>Current consensus DPS estimate is <strong>4.2<\/strong>, implying a prospective dividend yield of <strong>1.1%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>32.8<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>1.0<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"EVS\">EVS<\/a>&nbsp;&nbsp;&nbsp; ENVIROSUITE LIMITED<\/h2>\n<p><strong>Industrial Sector Contractors &amp; Engineers &#8211; Overnight Price: $0.18 <\/strong><\/p>\n<p>Bell Potter rates ((EVS)) as Buy (1) &#8211;<\/p>\n<p>Envirosuite&#039;s&nbsp;reported FY21 revenue of $48.6m was in line with Bell Potter&#039;s forecast and company guidance, while underlying earnings loss of -$4.5m was a beat on the broker&#039;s expected -$5.4m.<\/p>\n<p>Bell Potter notes the better-than-expected result was driven by lower operating expenditure and cost of goods.&nbsp;<\/p>\n<p>It was also noted that Envirosuite ended the year with a cash balance of $17.6m, ahead of the broker&#039;s forecast, and no bank debt. Bell Potter is forecasting mid to high teens percentage growth in FY22 and FY23, and expects a lower underlying earnings loss in the coming year but an underlying earnings profit in FY23.&nbsp;<\/p>\n<p>The Buy rating is retained and the target price increases to $0.175 from $0.15.<\/p>\n<p>This report was published on August 19, 2021.<\/p>\n<p>Target price is <strong>$0.18<\/strong> Current Price is <strong>$0.18 <\/strong> Difference: <strong>minus $0.005<\/strong> (current price is over target).<br \/>If <strong>EVS<\/strong> meets the Bell Potter target it will return approximately <strong>minus 3%<\/strong> (excluding dividends, fees and charges &#8211; negative figures indicate an expected loss).<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY22<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>minus 1.00<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>minus 18.00<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY23<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>minus 0.70<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>minus 25.71<\/strong>.<\/p>\n<\/blockquote>\n<p>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"FPH\">FPH<\/a>&nbsp;&nbsp;&nbsp; FISHER &amp; PAYKEL HEALTHCARE CORPORATION LIMITED<\/h2>\n<p><strong>Medical Equipment &amp; Devices &#8211; Overnight Price: $30.34 <\/strong><\/p>\n<p>Wilsons rates ((FPH)) as Overweight (1) &#8211;<\/p>\n<p>Fisher &amp; Paykel Healthcare&#039;s first four month results for FY21 are tracking ahead of Wilsons&#039; model, with revenue of NZ$583m around 9% ahead of the broker&#039;s expectations. The broker explains results are largely from Hardware sales outside the major markets.<\/p>\n<p>Wilsons notes the New Apps segment, which includes OptiFlow, was up 17% on the previous corresponding period. The broker points to ongoing practice change towards use of high flow nasal cannula as a driver of results.&nbsp;<\/p>\n<p>The Overweight rating and target price of $35.00 are&nbsp;retained.<\/p>\n<p>This report was published on August 18, 2021.<\/p>\n<p>Target price is <strong>$35.00<\/strong> Current Price is <strong>$30.34 <\/strong> Difference: <strong>$4.66<\/strong><br \/>If <strong>FPH<\/strong> meets the Wilsons target it will return approximately <strong> 15%<\/strong> (excluding dividends, fees and charges).<br \/>Current consensus price target is <strong>$32.50<\/strong>, suggesting upside of <strong>6.9%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in March.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Wilsons forecasts a full year <strong>FY22<\/strong> dividend of <strong>37.44<\/strong> cents and EPS of <strong>65.14<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>1.23%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>46.58<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>63.1<\/strong>, implying annual growth of <strong>N\/A<\/strong>.<br \/>Current consensus DPS estimate is <strong>37.9<\/strong>, implying a prospective dividend yield of <strong>1.2%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>48.2<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Wilsons forecasts a full year <strong>FY23<\/strong> dividend of <strong>38.37<\/strong> cents and EPS of <strong>66.64<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>1.26%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>45.53<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>64.6<\/strong>, implying annual growth of <strong>2.4%<\/strong>.<br \/>Current consensus DPS estimate is <strong>41.0<\/strong>, implying a prospective dividend yield of <strong>1.3%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>47.0<\/strong>.<\/p>\n<\/blockquote>\n<p>This company reports in <strong>NZD<\/strong>. All estimates have been converted into AUD by FNArena at present FX values.<br \/>Market Sentiment: <strong>-0.3<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"HDN\">HDN<\/a>&nbsp;&nbsp;&nbsp; HOMECO DAILY NEEDS REIT<\/h2>\n<p><strong>REITs &#8211; Overnight Price: $1.60 <\/strong><\/p>\n<p>Jarden rates ((HDN)) as Buy (1) &#8211;<\/p>\n<p>Homeco Daily Needs REIT reported its first full-year results, delivering a slight beat on Jarden&#039;s forecast with&nbsp;funds from operations per share of 4.1 cents.&nbsp;<\/p>\n<p>Portfolio occupancy increased to 99.3%&nbsp;from 98.7% and cash collections are approximately 99%. Jarden describes FY21 results as solid, and expects the company will remain active and acquisitive&nbsp;in FY22.&nbsp;<\/p>\n<p>The company also reiterated guidance for&nbsp;FY22 funds from operations per share of 8.3 cents and dividend per share of 8.0 cents. It is Jarden&#039;s view this shows management&#039;s optimistic outlook for the year ahead.&nbsp;<\/p>\n<p>The Buy rating is retained and the target price increases to $1.65 from $1.55.<\/p>\n<p>This report was issued on April 21, 2021.<\/p>\n<p>Target price is <strong>$1.65<\/strong> Current Price is <strong>$1.60 <\/strong> Difference: <strong>$0.05<\/strong><br \/>If <strong>HDN<\/strong> meets the Jarden target it will return approximately <strong> 3%<\/strong> (excluding dividends, fees and charges).<br \/>Current consensus price target is <strong>$1.65<\/strong>, suggesting upside of <strong>1.9%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Jarden forecasts a full year <strong>FY22<\/strong> dividend of <strong>8.00<\/strong> cents and EPS of <strong>8.80<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>5.00%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>18.18<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>8.6<\/strong>, implying annual growth of <strong>51.1%<\/strong>.<br \/>Current consensus DPS estimate is <strong>8.3<\/strong>, implying a prospective dividend yield of <strong>5.1%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>18.8<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Jarden forecasts a full year <strong>FY23<\/strong> dividend of <strong>8.40<\/strong> cents and EPS of <strong>8.80<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>5.25%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>18.18<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>9.1<\/strong>, implying annual growth of <strong>5.8%<\/strong>.<br \/>Current consensus DPS estimate is <strong>8.8<\/strong>, implying a prospective dividend yield of <strong>5.4%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>17.8<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>0.5<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"INA\">INA<\/a>&nbsp;&nbsp;&nbsp; INGENIA COMMUNITIES GROUP<\/h2>\n<p><strong>Aged Care &amp; Seniors &#8211; Overnight Price: $6.38 <\/strong><\/p>\n<p>Goldman Sachs rates ((INA)) as Neutral (3) &#8211;<\/p>\n<p>While&nbsp;Ingenia Communities Group has not provided FY22 guidance given ongoing restrictions along the east coast of Australia, Goldman Sachs notes&nbsp;the start to the year has been positive with 34 homes settled year-to-date and a strong pipeline of 330 homes deposited and contracted versus around 200 at beginning of FY21.<\/p>\n<p>Due to a&nbsp;disrupted near-term outlook for holidays, the broker cuts the FY22&nbsp;earning per share (EPS) forecast by -1.5%,&nbsp;however, higher medium-term settlements drive a 4.8% upgrade to FY23&nbsp;EPS.<\/p>\n<p>The broker notes acquisition remains a key element of Ingenia&rsquo;s growth strategy and believes the company has reasonable headroom to reach its target.<\/p>\n<p>Neutral rating is unchanged: Target price $6.75.<\/p>\n<p>This report was published on August 19, 2021.<\/p>\n<p>Target price is <strong>$6.75<\/strong> Current Price is <strong>$6.38 <\/strong> Difference: <strong>$0.37<\/strong><br \/>If <strong>INA<\/strong> meets the Goldman Sachs target it will return approximately <strong> 6%<\/strong> (excluding dividends, fees and charges).<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Goldman Sachs forecasts a full year <strong>FY22<\/strong> dividend of <strong>11.80<\/strong> cents and EPS of <strong>23.60<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>1.85%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>27.03<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Goldman Sachs forecasts a full year <strong>FY23<\/strong> dividend of <strong>16.70<\/strong> cents and EPS of <strong>33.40<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>2.62%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>19.10<\/strong>.<\/p>\n<\/blockquote>\n<p>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<hr \/>\n<p>Moelis rates ((INA)) as Hold (3) &#8211;<\/p>\n<p>Despite projecting 10% year-on-year&nbsp;growth in settlement volumes, Moelis expects&nbsp;Ingenia Communities Group&#039;s development&nbsp;earnings to only grow by 5% in FY22.<\/p>\n<p>This is due to a change in the project mix towards lower price-point projects such as Harvey Bay in QLD, which the broker notes&nbsp;should keep overall development earnings margins flat.<\/p>\n<p>The broker notes the group provides exposure to a growing defensive-growth annuity stream and network of holiday parks leveraged to strong underlying demand for domestic travel.<\/p>\n<p>Overall, Moelis expects earnings per share (EPS)&nbsp;compound annual growth rate (CAGR) of 9% between FY21-24&nbsp;based on the group&#039;s growing settlements profile and earnings contributions from acquisitions.<\/p>\n<p>The Hold rating is retained and the target price increases to $6.47 from $5.89.<\/p>\n<p>This&nbsp;report was published on August 19, 2021.<\/p>\n<p>Target price is <strong>$6.47<\/strong> Current Price is <strong>$6.38 <\/strong> Difference: <strong>$0.09<\/strong><br \/>If <strong>INA<\/strong> meets the Moelis target it will return approximately <strong> 1%<\/strong> (excluding dividends, fees and charges).<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Moelis forecasts a full year <strong>FY22<\/strong> dividend of <strong>11.70<\/strong> cents and EPS of <strong>24.60<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>1.83%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>25.93<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Moelis forecasts a full year <strong>FY23<\/strong> dividend of <strong>13.40<\/strong> cents and EPS of <strong>28.10<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>2.10%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>22.70<\/strong>.<\/p>\n<\/blockquote>\n<p>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"ING\">ING<\/a>&nbsp;&nbsp;&nbsp; INGHAMS GROUP LIMITED<\/h2>\n<p><strong>Food, Beverages &amp; Tobacco &#8211; Overnight Price: $4.10 <\/strong><\/p>\n<p>Goldman Sachs rates ((ING)) as Buy (1) &#8211;<\/p>\n<p>While covid is expected to continue to present&nbsp;challenges for first half FY22, Goldman Sachs believes Ingham Group&#039;s successful track record in handling the pandemic over the last 18 months means the company is well&nbsp;equipped to manage any disruption going forward.<\/p>\n<p>The broker notes that retail, which is by far the group&#039;s biggest channel,&nbsp;should continue to display strong demand in FY22.<\/p>\n<p>While working capital management has been strong over the half, the broker suspects that&nbsp;improving inventories may be compromised&nbsp;by further lockdown measures, plus any underlying weakening in wholesale and QSR channels.<\/p>\n<p>While&nbsp;no FY22 earnings guidance has been provided, the broker has marginally upgraded FY22\/FY23 earnings per share (EPS) estimates.<\/p>\n<p>The Buy rating and the target price of $4.50 are retained.<\/p>\n<p>This report was published on August 20, 2021.<\/p>\n<p>Target price is <strong>$4.50<\/strong> Current Price is <strong>$4.10 <\/strong> Difference: <strong>$0.4<\/strong><br \/>If <strong>ING<\/strong> meets the Goldman Sachs target it will return approximately <strong> 10%<\/strong> (excluding dividends, fees and charges).<br \/>Current consensus price target is <strong>$4.20<\/strong>, suggesting upside of <strong>2.9%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Goldman Sachs forecasts a full year <strong>FY22<\/strong> dividend of <strong>19.50<\/strong> cents and EPS of <strong>28.50<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>4.76%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>14.39<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>26.5<\/strong>, implying annual growth of <strong>18.1%<\/strong>.<br \/>Current consensus DPS estimate is <strong>17.5<\/strong>, implying a prospective dividend yield of <strong>4.3%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>15.4<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Goldman Sachs forecasts a full year <strong>FY23<\/strong> dividend of <strong>21.50<\/strong> cents and EPS of <strong>29.90<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>5.24%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>13.71<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>29.4<\/strong>, implying annual growth of <strong>10.9%<\/strong>.<br \/>Current consensus DPS estimate is <strong>19.6<\/strong>, implying a prospective dividend yield of <strong>4.8%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>13.9<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>0.4<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"IPH\">IPH<\/a>&nbsp;&nbsp;&nbsp; IPH LIMITED<\/h2>\n<p><strong>Legal &#8211; Overnight Price: $9.18 <\/strong><\/p>\n<p>Bell Potter rates ((IPH)) as Buy (1) &#8211;<\/p>\n<p>IPH Ltd recently acquired Applied Marks, an online trademark business, and is actively pursuing further opportunities, observes Bell Potter.<\/p>\n<p>The broker believes&nbsp;IPH is well placed as a leading &lsquo;one-stop gateway&rsquo; for Asia-Pacific and sees growth prospects emanating from the growth of the market itself, and market share gains.<\/p>\n<p>Having factored in the&nbsp;Applied Mark acquisition, and updates to&nbsp;model and forex assumptions, the broker&#039;s FY22, FY23, and FY24&nbsp;earnings per share (EPS) estimates&nbsp;increase by low to mid-single-digits.<\/p>\n<p>The Buy rating is unchanged and the target price increases to $9.90 from $8.15.<\/p>\n<p>This report was published on August 20, 2021.<\/p>\n<p>Target price is <strong>$9.90<\/strong> Current Price is <strong>$9.18 <\/strong> Difference: <strong>$0.72<\/strong><br \/>If <strong>IPH<\/strong> meets the Bell Potter target it will return approximately <strong> 8%<\/strong> (excluding dividends, fees and charges).<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY22<\/strong> dividend of <strong>30.00<\/strong> cents and EPS of <strong>38.70<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>3.27%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>23.72<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY23<\/strong> dividend of <strong>33.00<\/strong> cents and EPS of <strong>42.20<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>3.59%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>21.75<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>1.0<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<hr \/>\n<p>Jarden rates ((IPH)) as Buy (1) &#8211;<\/p>\n<p>IPH has delivered a solid earnings beat in FY21, with underlying earnings of $124.3m and revenue of $363.5m. It is Jarden&#039;s view the company has reported good&nbsp;results that highlight operating leverage and strong momentum in the Asian business.&nbsp;<\/p>\n<p>The broker notes IPH has been highly acquisitive and estimates the company to have a debt-funded acquisition capacity of around $240m.<\/p>\n<p>Jarden has updated underlying earnings forecasts by 4% across FY22 and FY23 on higher margin assumptions. The Buy rating is retained and the target price increases to $9.49 from $8.55.&nbsp;<\/p>\n<p>This report was published on August 19, 2021.&nbsp;<\/p>\n<p>Target price is <strong>$9.49<\/strong> Current Price is <strong>$9.18 <\/strong> Difference: <strong>$0.31<\/strong><br \/>If <strong>IPH<\/strong> meets the Jarden target it will return approximately <strong> 3%<\/strong> (excluding dividends, fees and charges).<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Jarden forecasts a full year <strong>FY22<\/strong> dividend of <strong>38.40<\/strong> cents and EPS of <strong>38.40<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>4.18%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>23.91<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Jarden forecasts a full year <strong>FY23<\/strong> dividend of <strong>42.00<\/strong> cents and EPS of <strong>42.00<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>4.58%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>21.86<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>1.0<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"IRI\">IRI<\/a>&nbsp;&nbsp;&nbsp; INTEGRATED RESEARCH LIMITED<\/h2>\n<p><strong>IT &amp; Support &#8211; Overnight Price: $1.86 <\/strong><\/p>\n<p>Bell Potter rates ((IRI)) as Hold (3) &#8211;<\/p>\n<p>Integrated Research&#039;s&nbsp;FY21 net profit&nbsp;was down -67% but was 9% above Bell Potter&#039;s forecast due largely to&nbsp;lower&nbsp;forex losses than the broker was expecting.<\/p>\n<p>While Integrated Research&nbsp;did not provide any FY22 guidance,&nbsp;the company&#039;s FY22 action plan reveals plans to accelerate the transition to SaaS benefits. Another key&nbsp;performance indicator highlighted by the company for FY22&nbsp;includes 75 new customers and 100% growth in cloud deferred revenue backlog, observes Bell Potter.<\/p>\n<p>The broker&nbsp;is forecasting a rebound in FY22 after the tough FY21 and forecasts low double-digit revenue growth and strong double-digit earnings growth.<\/p>\n<p>The Hold rating is unchanged and the target price is lowered to $2.10 from $2.25.<\/p>\n<p>This report was published on August 20, 2021.<\/p>\n<p>Target price is <strong>$2.10<\/strong> Current Price is <strong>$1.86 <\/strong> Difference: <strong>$0.24<\/strong><br \/>If <strong>IRI<\/strong> meets the Bell Potter target it will return approximately <strong> 13%<\/strong> (excluding dividends, fees and charges).<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY22<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>6.00<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>31.00<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY23<\/strong> dividend of <strong>1.00<\/strong> cents and EPS of <strong>9.00<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>0.54%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>20.67<\/strong>.<\/p>\n<\/blockquote>\n<p>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"LIC\">LIC<\/a>&nbsp;&nbsp;&nbsp; LIFESTYLE COMMUNITIES LIMITED<\/h2>\n<p><strong>Aged Care &amp; Seniors &#8211; Overnight Price: $22.00 <\/strong><\/p>\n<p>Canaccord Genuity rates ((LIC)) as Hold (3) &#8211;<\/p>\n<p>Lifestyle Communities&#039; FY21&nbsp;result was in line with the guidance provided in July, and the company has guided to 1100-1300 new home settlements between FY22-FY24.<\/p>\n<p>While the plan remains to add two new sites per year, Canaccord Genuity notes the sites are becoming larger.<\/p>\n<p>As a result, the broker has&nbsp;increased assumptions in the&nbsp;future pipeline to 225 homes per community and this has increased the future assumed pipeline to 4,500 homes, an uplift of 40%.<\/p>\n<p>While the company is trading at a 9% premium to Canaccord&#039;s&nbsp;valuation, in the broker&#039;s&nbsp;view it remains one of the best long-term exposures to the aging population thematic, offering a superior business model, product, and management team.<\/p>\n<p>Hold&nbsp;rating unchanged, and the target price is increased to $17.30 from $13.40.<\/p>\n<p>The report was published on August 19, 2021.<\/p>\n<p>Target price is <strong>$17.30<\/strong> Current Price is <strong>$22.00 <\/strong> Difference: <strong>minus $4.7<\/strong> (current price is over target).<br \/>If <strong>LIC<\/strong> meets the Canaccord Genuity target it will return approximately <strong>minus 21%<\/strong> (excluding dividends, fees and charges &#8211; negative figures indicate an expected loss).<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Canaccord Genuity forecasts a full year <strong>FY22<\/strong> dividend of <strong>10.00<\/strong> cents and EPS of <strong>63.00<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>0.45%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>34.92<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Canaccord Genuity forecasts a full year <strong>FY23<\/strong> dividend of <strong>12.00<\/strong> cents and EPS of <strong>69.40<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>0.55%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>31.70<\/strong>.<\/p>\n<\/blockquote>\n<p>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<hr \/>\n<p>Goldman Sachs rates ((LIC)) as Buy (1) &#8211;<\/p>\n<p>Goldman Sachs expects&nbsp;Lifestyle Communities&#039;&nbsp;strong 3-year guidance for FY22-FY24&nbsp;new home settlements and resales&nbsp;to drive materially higher annuity rental and deferred management fee (DMF) earnings over the long term.<\/p>\n<p>The broker expects the upsizing of the debt facility by $100m to $375m will allow for further property acquisitions, ultimately driving a faster pace of new home settlements, leading to a larger rental and DMF annuity.<\/p>\n<p>The broker notes while&nbsp;FY22 and FY23 earnings per share (EPS) changes appear minor, resales and rental income have been upgraded circa 12% which has been offset by slightly lower development margins due to mix.<\/p>\n<p>The Buy rating is retained and the target price increases 21% to $21.60.<\/p>\n<p>This report was published on August 19, 2021.<\/p>\n<p>Target price is <strong>$21.60<\/strong> Current Price is <strong>$22.00 <\/strong> Difference: <strong>minus $0.4<\/strong> (current price is over target).<br \/>If <strong>LIC<\/strong> meets the Goldman Sachs target it will return approximately <strong>minus 2%<\/strong> (excluding dividends, fees and charges &#8211; negative figures indicate an expected loss).<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Goldman Sachs forecasts a full year <strong>FY22<\/strong> dividend of <strong>10.10<\/strong> cents and EPS of <strong>56.70<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>0.46%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>38.80<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Goldman Sachs forecasts a full year <strong>FY23<\/strong> dividend of <strong>11.90<\/strong> cents and EPS of <strong>61.50<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>0.54%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>35.77<\/strong>.<\/p>\n<\/blockquote>\n<p>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"MMM\">MMM<\/a>&nbsp;&nbsp;&nbsp; MARLEY SPOON AG<\/h2>\n<p><strong>Consumer Products &amp; Services &#8211; Overnight Price: $1.78 <\/strong><\/p>\n<p>Wilsons rates ((MMM)) as Overweight (1) &#8211;<\/p>\n<p>While Marley Spoon delivered a &quot;mixed&quot; second half FY21 result, Wilsons is impressed with sales growth (up 36%) offset by higher costs, as recently outlined in the second quarter FY21 result.<\/p>\n<p>During the half, revenue increased 36% on the previous period, while an earnings loss of -EUR15.6m was significantly greater than the -EUR2.2m loss in first half FY20, due to contribution margin compression, plus higher marketing and general and admin expense.<\/p>\n<p>Marley Spoon confirmed guidance for 2021 revenue growth of 30-35% and a margin of 29%.<\/p>\n<p>Wilsons continues to see significant&nbsp;upside to&nbsp;forecasts if the current trajectory of revenue growth continues.<\/p>\n<p>The Overweight rating is retained and the target price is reduced to $3.17 from $3.85.&nbsp;<\/p>\n<p>This report was published on August 20, 2021.<\/p>\n<p>Target price is <strong>$3.17<\/strong> Current Price is <strong>$1.78 <\/strong> Difference: <strong>$1.39<\/strong><br \/>If <strong>MMM<\/strong> meets the Wilsons target it will return approximately <strong> 78%<\/strong> (excluding dividends, fees and charges).<br \/>The company&#039;s fiscal year ends in December.<\/p>\n<p><strong>Forecast for FY21:<\/strong><\/p>\n<blockquote>\n<p>Wilsons forecasts a full year <strong>FY21<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>minus 26.40<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>minus 6.74<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Wilsons forecasts a full year <strong>FY22<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>minus 19.72<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>minus 9.02<\/strong>.<\/p>\n<\/blockquote>\n<p>This company reports in <strong>EUR<\/strong>. All estimates have been converted into AUD by FNArena at present FX values.<br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"MNY\">MNY<\/a>&nbsp;&nbsp;&nbsp; MONEY3 CORPORATION LIMITED<\/h2>\n<p><strong>Business &amp; Consumer Credit &#8211; Overnight Price: $3.48 <\/strong><\/p>\n<p>Bell Potter rates ((MNY)) as Buy (1) &#8211;<\/p>\n<p>Money3 Corp&#039;s FY21 results were exceptionally strong according to Bell Potter. The company delivered profit after tax of $39.2m and underlying earnings of $82.4m,&nbsp;a 35.8% year-on-year increase.<\/p>\n<p>Bell Potter highlights results were driven by 38.5% loan book growth to $600.9m, and firm credit quality control. The company is yet to provide formal guidance for FY22, but expects to achieve more than 20% year-on-year earnings growth.&nbsp;<\/p>\n<p>The broker increases earnings per share estimates by 0.2% and&nbsp;5.6% for FY22 and FY23 respectively.&nbsp;<\/p>\n<p>The Buy rating is retained and the target price increases to $4.15 from $3.70.<\/p>\n<p>This report was published on August 19, 2021.<\/p>\n<p>Target price is <strong>$4.15<\/strong> Current Price is <strong>$3.48 <\/strong> Difference: <strong>$0.67<\/strong><br \/>If <strong>MNY<\/strong> meets the Bell Potter target it will return approximately <strong> 19%<\/strong> (excluding dividends, fees and charges).<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY22<\/strong> dividend of <strong>11.40<\/strong> cents and EPS of <strong>22.50<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>3.28%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>15.47<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY23<\/strong> dividend of <strong>14.50<\/strong> cents and EPS of <strong>28.60<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>4.17%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>12.17<\/strong>.<\/p>\n<\/blockquote>\n<p>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"NCM\">NCM<\/a>&nbsp;&nbsp;&nbsp; NEWCREST MINING LIMITED<\/h2>\n<p><strong>Gold &amp; Silver &#8211; Overnight Price: $24.47 <\/strong><\/p>\n<p>Goldman Sachs rates ((NCM)) as Buy (1) &#8211;<\/p>\n<p>While Newcrest Mining&#039;s&nbsp;FY22 guidance was softer than Goldman Sachs&#039; expectations, especially due to higher than expected all-in costs at key assets, higher capex, gold and copper production guidance were in line with the broker&#039;s previous&nbsp;estimates at the group level.<\/p>\n<p>Lihir&rsquo;s outlook proved -10-20% below the broker&#039;s earlier&nbsp;forecasts, offset by stronger&nbsp;production expectations at Telfer.<\/p>\n<p>Meantime, Newcrest&#039;s&nbsp;major project pipeline, which continues to progress, including studies at&nbsp;Cadia, Red Chris block cave, Lihir&nbsp;and Havieron.<\/p>\n<p>Goldman Sachs&nbsp;has reduced&nbsp;FY22 earnings by high single digits on&nbsp;weaker than expected&nbsp;FY22 all-in cost guidance. After carrying forward higher operating costs at Cadia, and higher corporate costs and provisions, the broker has reduced net asset value by -6% to $33.68\/sh.<\/p>\n<p>The Buy rating is retained and the target price is lowered to $33.00 from $34.00.&nbsp;<\/p>\n<p>This report was published on August 20, 2021.&nbsp;<\/p>\n<p>Target price is <strong>$33.00<\/strong> Current Price is <strong>$24.47 <\/strong> Difference: <strong>$8.53<\/strong><br \/>If <strong>NCM<\/strong> meets the Goldman Sachs target it will return approximately <strong> 35%<\/strong> (excluding dividends, fees and charges).<br \/>Current consensus price target is <strong>$29.63<\/strong>, suggesting upside of <strong>20.6%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Goldman Sachs forecasts a full year <strong>FY22<\/strong> dividend of <strong>21.28<\/strong> cents and EPS of <strong>200.19<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>0.87%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>12.22<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>134.4<\/strong>, implying annual growth of <strong>N\/A<\/strong>.<br \/>Current consensus DPS estimate is <strong>37.6<\/strong>, implying a prospective dividend yield of <strong>1.5%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>18.3<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Goldman Sachs forecasts a full year <strong>FY23<\/strong> dividend of <strong>35.91<\/strong> cents and EPS of <strong>248.74<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>1.47%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>9.84<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>138.3<\/strong>, implying annual growth of <strong>2.9%<\/strong>.<br \/>Current consensus DPS estimate is <strong>41.3<\/strong>, implying a prospective dividend yield of <strong>1.7%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>17.8<\/strong>.<\/p>\n<\/blockquote>\n<p>This company reports in <strong>USD<\/strong>. All estimates have been converted into AUD by FNArena at present FX values.<br \/>Market Sentiment: <strong>0.7<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"NEA\">NEA<\/a>&nbsp;&nbsp;&nbsp; NEARMAP LIMITED<\/h2>\n<p><strong>Software &amp; Services &#8211; Overnight Price: $1.94 <\/strong><\/p>\n<p>Canaccord Genuity rates ((NEA)) as Buy (1) &#8211;<\/p>\n<p>Following a reported FY21 result that was broadly in line with market expectations, Nearmap&nbsp;noted it expects to capitalise on strong momentum and retained its medium-term target to grow annual contract value between 20% and 40%, with the North American portfolio to surpass that of A&amp;NZ in FY22.<\/p>\n<p>The broker&#039;s Buy rating and target price of $3.15 are both&nbsp;unchanged.&nbsp;<\/p>\n<p>The report was first published on August 18,&nbsp;2021.<\/p>\n<p>Target price is <strong>$3.15<\/strong> Current Price is <strong>$1.94 <\/strong> Difference: <strong>$1.21<\/strong><br \/>If <strong>NEA<\/strong> meets the Canaccord Genuity target it will return approximately <strong> 62%<\/strong> (excluding dividends, fees and charges).<br \/>Current consensus price target is <strong>$2.58<\/strong>, suggesting upside of <strong>33.9%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Canaccord Genuity forecasts a full year <strong>FY22<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>minus 6.00<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>minus 32.33<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>-4.2<\/strong>, implying annual growth of <strong>N\/A<\/strong>.<br \/>Current consensus DPS estimate is <strong>N\/A<\/strong>, implying a prospective dividend yield of <strong>N\/A<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>N\/A<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Canaccord Genuity forecasts a full year <strong>FY23<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>minus 4.00<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>minus 48.50<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>0.8<\/strong>, implying annual growth of <strong>N\/A<\/strong>.<br \/>Current consensus DPS estimate is <strong>N\/A<\/strong>, implying a prospective dividend yield of <strong>N\/A<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>241.3<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>0.3<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"NWH\">NWH<\/a>&nbsp;&nbsp;&nbsp; NRW HOLDINGS LIMITED<\/h2>\n<p><strong>Mining Sector Contracting &#8211; Overnight Price: $1.86 <\/strong><\/p>\n<p>Euroz Hartleys rates ((NWH)) as Initiation of coverage with Buy (1) &#8211;<\/p>\n<p>NRW Holdings has guided the market in FY22 to revenues between $2.4bn and $2.5bn, generating earnings of between $145m and $155m, up strongly on FY21.<\/p>\n<p><strong>&nbsp;<\/strong>Euroz&nbsp;Hartleys&nbsp;notes the forecasts are supported by $2bn in visible revenue and $14.5bn of (within 12 months) opportunity.<\/p>\n<p>The broker believes the FY21 result, which was at&nbsp;the higher end of guidance, plus the outlook statement, with a little explanation, should go a long way to driving share price momentum over the short and medium-term.<\/p>\n<p>Fundamentally, <strong>&nbsp;<\/strong>Euroz&nbsp;Hartleys&nbsp;believes&nbsp;the investment case is well supported by long-term management track record, the order book, balance sheet, outlook statement, and dividend.<\/p>\n<p>The broker notes catalysts include contract wins in the normal course and improving margins. Buy rating: Target $3.06.<\/p>\n<p>This report was issued on August 19, 2021.<\/p>\n<p>Target price is <strong>$3.06<\/strong> Current Price is <strong>$1.86 <\/strong> Difference: <strong>$1.2<\/strong><br \/>If <strong>NWH<\/strong> meets the Euroz Hartleys target it will return approximately <strong> 65%<\/strong> (excluding dividends, fees and charges).<\/p>\n<p>Market Sentiment: <strong>1.0<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<hr \/>\n<p>Jarden rates ((NWH)) as Overweight (2) &#8211;<\/p>\n<p>NRW Holdings&#039; FY21 result was strong given expected labour cost inflation and weather impacts, according to Jarden. The company reported operating earnings of around $121m.&nbsp;<\/p>\n<p>Jarden notes the result was driven by additional contributions from recent acquisitions, recovery in mining margins, and a strengthening outlook into FY22. Looking ahead, the company is guiding to FY22 revenue of $2.4-2.5bn, with $2bn of&nbsp;this covered by work-in-hand, and operating earnings of $145-155m.&nbsp;<\/p>\n<p>The Overweight rating and target price of $2.90 are retained.&nbsp;<\/p>\n<p>This report was published on August 19, 2021.<\/p>\n<p>Target price is <strong>$2.90<\/strong> Current Price is <strong>$1.86 <\/strong> Difference: <strong>$1.04<\/strong><br \/>If <strong>NWH<\/strong> meets the Jarden target it will return approximately <strong> 56%<\/strong> (excluding dividends, fees and charges).<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Jarden forecasts a full year <strong>FY22<\/strong> dividend of <strong>12.30<\/strong> cents and EPS of <strong>22.20<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>6.61%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>8.38<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Jarden forecasts a full year <strong>FY23<\/strong> dividend of <strong>13.50<\/strong> cents and EPS of <strong>24.20<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>7.26%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>7.69<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>1.0<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"NWL\">NWL<\/a>&nbsp;&nbsp;&nbsp; NETWEALTH GROUP LIMITED<\/h2>\n<p><strong>Wealth Management &amp; Investments &#8211; Overnight Price: $14.59 <\/strong><\/p>\n<p>Goldman Sachs rates ((NWL)) as Neutral (3) &#8211;<\/p>\n<p>Goldman Sachs notes the three key outlook items flagged by&nbsp;Netweath&nbsp;Group include&nbsp;funds under advice (FUA) net flows guidance for FY22 of circa $10bn, while the group is not expecting material change to the admin fee margin in FY22, with the impact of recent repricing now in the base.<\/p>\n<p>The broker also notes the group will strategically step up its investment in people and tech over FY22, after which growth in expenses will normalise in FY23.<\/p>\n<p>On balance, Goldman Sachs downgrades FY22-23&nbsp;earnings per share (EPS) by -5.4% and -1.3% respectively, and also introduces FY24 estimates.<\/p>\n<p>Goldman Sachs notes&nbsp;downgrades&nbsp;are primarily a function of slightly higher admin fee margins based on recent outlook comments, against a rebased expense profile where the broker now forecast a -3% reduction in earnings margin into FY22.<\/p>\n<p>The Neutral rating remains and the target price is lowered to $15.33 from $16.33.<\/p>\n<p>This report was published on August 18, 2021.&nbsp;<\/p>\n<p>Target price is <strong>$15.33<\/strong> Current Price is <strong>$14.59 <\/strong> Difference: <strong>$0.74<\/strong><br \/>If <strong>NWL<\/strong> meets the Goldman Sachs target it will return approximately <strong> 5%<\/strong> (excluding dividends, fees and charges).<br \/>Current consensus price target is <strong>$16.53<\/strong>, suggesting upside of <strong>11.7%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Goldman Sachs forecasts a full year <strong>FY22<\/strong> dividend of <strong>21.00<\/strong> cents and EPS of <strong>25.00<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>1.44%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>58.36<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>25.8<\/strong>, implying annual growth of <strong>14.4%<\/strong>.<br \/>Current consensus DPS estimate is <strong>20.9<\/strong>, implying a prospective dividend yield of <strong>1.4%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>57.4<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Goldman Sachs forecasts a full year <strong>FY23<\/strong> dividend of <strong>25.00<\/strong> cents and EPS of <strong>30.00<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>1.71%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>48.63<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>30.0<\/strong>, implying annual growth of <strong>16.3%<\/strong>.<br \/>Current consensus DPS estimate is <strong>24.1<\/strong>, implying a prospective dividend yield of <strong>1.6%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>49.3<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>0.6<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"OBL\">OBL<\/a>&nbsp;&nbsp;&nbsp; OMNI BRIDGEWAY LIMITED<\/h2>\n<p><strong>Diversified Financials &#8211; Overnight Price: $3.65 <\/strong><\/p>\n<p>Euroz Hartleys rates ((OBL)) as Buy (1) &#8211;<\/p>\n<p>Omni Bridgeway&#039;s&nbsp;FY21 results were broadly&nbsp;as&nbsp;Euroz Hartleys&#039; had expected with commentary providing line of sight of what the broker sees as heightened front-end activity.<\/p>\n<p>Euroz Hartleys&nbsp;remains comfortable with&nbsp;2022 and 2023 forecasts and is&nbsp;looking for significantly improved profitability during these periods.<\/p>\n<p>Estimated Portfolio Value (EPV) is at $20.1m, up from $15.8m over the previous period and committed funds increased from $312m in 2020 to $413m in 2021.<\/p>\n<p>The broker notes&nbsp;forecasts for 2022 are largely underpinned by an outcome on Wivenhoe.&nbsp;Buy rating.&nbsp;Price target $5.65.<\/p>\n<p>This report was issued August 20, 2021.<\/p>\n<p>Target price is <strong>$5.65<\/strong> Current Price is <strong>$3.65 <\/strong> Difference: <strong>$2<\/strong><br \/>If <strong>OBL<\/strong> meets the Euroz Hartleys target it will return approximately <strong> 55%<\/strong> (excluding dividends, fees and charges).<\/p>\n<p>Market Sentiment: <strong>1.0<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"OTW\">OTW<\/a>&nbsp;&nbsp;&nbsp; OVER THE WIRE HOLDINGS LIMITED<\/h2>\n<p><strong>Cloud services &#8211; Overnight Price: $4.64 <\/strong><\/p>\n<p>Bell Potter rates ((OTW)) as Hold (3) &#8211;<\/p>\n<p>While Over the Wire Holdings did not provide any FY22 guidance, the company is targeting 15% organic recurring revenue growth in FY22 which is consistent with recent years, observes Bell Potter.<\/p>\n<p>Over the Wire also signaled plans to &ldquo;maximise opportunities, operational leverage, and savings from completion of Tier 1 voice provider&rdquo;.<\/p>\n<p>Largely&nbsp;driven by reductions in margin estimates plus modest reductions in revenue forecasts, Bell Potter has&nbsp;downgraded&nbsp;FY22 and FY23 earnings&nbsp;forecasts by 8% and 5% respectively.<\/p>\n<p>The Hold rating and target price of $5.00 are retained.&nbsp;<\/p>\n<p>This report was published on August 20, 2021.&nbsp;<\/p>\n<p>Target price is <strong>$5.00<\/strong> Current Price is <strong>$4.64 <\/strong> Difference: <strong>$0.36<\/strong><br \/>If <strong>OTW<\/strong> meets the Bell Potter target it will return approximately <strong> 8%<\/strong> (excluding dividends, fees and charges).<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY22<\/strong> dividend of <strong>4.50<\/strong> cents and EPS of <strong>11.40<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>0.97%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>40.70<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY23<\/strong> dividend of <strong>5.50<\/strong> cents and EPS of <strong>16.10<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>1.19%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>28.82<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>0.5<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"OZL\">OZL<\/a>&nbsp;&nbsp;&nbsp; OZ MINERALS LIMITED<\/h2>\n<p><strong>Copper &#8211; Overnight Price: $24.94 <\/strong><\/p>\n<p>Goldman Sachs rates ((OZL)) as Neutral (3) &#8211;<\/p>\n<p>As expected, Goldman Sachs notes OZ Minerals&nbsp;approved the Prominent Hill underground expansion to 6Mtpa while&nbsp;capex has increased by circa 30% to $600m&nbsp;due to scope changes and industry cost inflation.<\/p>\n<p>The broker&nbsp;had&nbsp;already assumed 10-15% capex inflation across the company&#039;s $3bn of growth spend across the portfolio.<\/p>\n<p>Goldman Sachs&nbsp;increases 2021 and&nbsp;2022 earning per share by 8% and 13% after lowering costs, and the broker&#039;s net asset value&nbsp; estimate is down -1% to $25.8\/sh on higher capex at Prominent Hill<\/p>\n<p>The Neutral rating is retained with the&nbsp;target price increasing 0.4% to $25.40.<\/p>\n<p>This report was published on August 18, 2021.<\/p>\n<p>Target price is <strong>$25.40<\/strong> Current Price is <strong>$24.94 <\/strong> Difference: <strong>$0.46<\/strong><br \/>If <strong>OZL<\/strong> meets the Goldman Sachs target it will return approximately <strong> 2%<\/strong> (excluding dividends, fees and charges).<br \/>Current consensus price target is <strong>$23.69<\/strong>, suggesting downside of <strong>-2.6%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in December.<\/p>\n<p><strong>Forecast for FY21:<\/strong><\/p>\n<blockquote>\n<p>Goldman Sachs forecasts a full year <strong>FY21<\/strong> dividend of <strong>37.40<\/strong> cents and EPS of <strong>189.00<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>1.50%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>13.20<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>167.3<\/strong>, implying annual growth of <strong>156.5%<\/strong>.<br \/>Current consensus DPS estimate is <strong>33.2<\/strong>, implying a prospective dividend yield of <strong>1.4%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>14.5<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Goldman Sachs forecasts a full year <strong>FY22<\/strong> dividend of <strong>50.60<\/strong> cents and EPS of <strong>253.00<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>2.03%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>9.86<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>154.0<\/strong>, implying annual growth of <strong>-7.9%<\/strong>.<br \/>Current consensus DPS estimate is <strong>30.8<\/strong>, implying a prospective dividend yield of <strong>1.3%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>15.8<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>0.3<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<hr \/>\n<p>Shaw and Partners rates ((OZL)) as Buy (1) &#8211;<\/p>\n<p>Operational performance, higher copper volumes and stronger prices have driven a beat for OZ Minerals in the first half of FY21. The company reported a 237% increase in profit after tax for the half, to total $269m, an approximate 15% beat on consensus forecasts.<\/p>\n<p>OZ Minerals also announced a fully franked 8 cent per share dividend, as well as an 8 cent per share special dividend from strong financial performance.&nbsp;<\/p>\n<p>The company has signed off on the final investment decision for Prominent Hill, extending mine life, lowering operating costs, increasing annual production and enabling lower emissions.&nbsp;<\/p>\n<p>The Buy rating is retained and the target price decreases to $22.50 from $25.00.&nbsp;<\/p>\n<p>This report was published on August 19, 2021.<\/p>\n<p>Target price is <strong>$22.50<\/strong> Current Price is <strong>$24.94 <\/strong> Difference: <strong>minus $2.44<\/strong> (current price is over target).<br \/>If <strong>OZL<\/strong> meets the Shaw and Partners target it will return approximately <strong>minus 10%<\/strong> (excluding dividends, fees and charges &#8211; negative figures indicate an expected loss).<br \/>Current consensus price target is <strong>$23.69<\/strong>, suggesting downside of <strong>-2.6%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in December.<\/p>\n<p><strong>Forecast for FY21:<\/strong><\/p>\n<blockquote>\n<p>Shaw and Partners forecasts a full year <strong>FY21<\/strong> dividend of <strong>25.00<\/strong> cents and EPS of <strong>160.90<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>1.00%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>15.50<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>167.3<\/strong>, implying annual growth of <strong>156.5%<\/strong>.<br \/>Current consensus DPS estimate is <strong>33.2<\/strong>, implying a prospective dividend yield of <strong>1.4%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>14.5<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Shaw and Partners forecasts a full year <strong>FY22<\/strong> dividend of <strong>30.00<\/strong> cents and EPS of <strong>158.40<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>1.20%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>15.74<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>154.0<\/strong>, implying annual growth of <strong>-7.9%<\/strong>.<br \/>Current consensus DPS estimate is <strong>30.8<\/strong>, implying a prospective dividend yield of <strong>1.3%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>15.8<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>0.3<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"PME\">PME<\/a>&nbsp;&nbsp;&nbsp; PRO MEDICUS LIMITED<\/h2>\n<p><strong>Medical Equipment &amp; Devices &#8211; Overnight Price: $58.85 <\/strong><\/p>\n<p>Bell Potter rates ((PME)) as Hold (3) &#8211;<\/p>\n<p>Pro Medicus&#039; FY21 revenue of $68m implies 19% growth on the previous year, and 35% growth in the second half. The company also reported&nbsp;earnings margin improvement to 62%.<\/p>\n<p>It is Bell Potter&#039;s view that Pro Medicus continues to be attractive, highlighting the company&#039;s demonstrated ability to leverage earnings potential, having increased&nbsp;revenue by $20m in the last two years while increasing cash operating expenses only by -$1.3m, and a strong customer base that includes 9 of the top 20 US hospitals.<\/p>\n<p>Looking forward, the broker notes the company has a full pipeline, including at least two contracts signed in FY21 that are yet to be implemented. Bell Potter expects the company will deliver solid revenue and earnings growth in FY22.&nbsp;<\/p>\n<p>The Hold rating is retained and the target price increases to $62.00.<\/p>\n<p>This report was published on August 19, 2021.<\/p>\n<p>Target price is <strong>$62.00<\/strong> Current Price is <strong>$58.85 <\/strong> Difference: <strong>$3.15<\/strong><br \/>If <strong>PME<\/strong> meets the Bell Potter target it will return approximately <strong> 5%<\/strong> (excluding dividends, fees and charges).<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY22<\/strong> dividend of <strong>20.50<\/strong> cents and EPS of <strong>40.90<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>0.35%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>143.89<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY23<\/strong> dividend of <strong>26.50<\/strong> cents and EPS of <strong>53.00<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>0.45%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>111.04<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>-0.5<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<hr \/>\n<p>Moelis rates ((PME)) as Downgrade to Sell from Hold (5) &#8211;<\/p>\n<p>While no quantified guidance was provided following Pro Medicus&#039; FY21 underlying net profit&nbsp;result, which was 4% ahead of consensus, the company noted that despite record contract wins in FY21, the pipeline remains &quot;healthy&quot; in terms of both quality and quantity.<\/p>\n<p>Moelis believes strong growth in FY22 is largely underwritten by the 5 large US contracts already announced in FY21. With a healthy pipeline of opportunities and an increased demand for cloud-based solutions (allowing more rapid deployment), the broker assumes the company will win another 3 large contracts in FY22, which will contribute to second half FY22.<\/p>\n<p>From FY23 and beyond Moelis assumes&nbsp;the company will&nbsp;achieve&nbsp;$22.5m pa from new contracts.<\/p>\n<p>The broke estimates -5% earnings per share (EPS) reductions capture costs returning in FY22, while outer years earnings estimates increase to capture 30% peak penetration.<\/p>\n<p>Moelis downgrades Pro Medicus to Sell from Hold with the target increasing to $51.61 from&nbsp;$47.17.<\/p>\n<p>This report was published on August 18, 2021.<\/p>\n<p>Target price is <strong>$51.61<\/strong> Current Price is <strong>$58.85 <\/strong> Difference: <strong>minus $7.24<\/strong> (current price is over target).<br \/>If <strong>PME<\/strong> meets the Moelis target it will return approximately <strong>minus 12%<\/strong> (excluding dividends, fees and charges &#8211; negative figures indicate an expected loss).<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Moelis forecasts a full year <strong>FY22<\/strong> dividend of <strong>19.00<\/strong> cents and EPS of <strong>42.40<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>0.32%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>138.80<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Moelis forecasts a full year <strong>FY23<\/strong> dividend of <strong>22.50<\/strong> cents and EPS of <strong>55.50<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>0.38%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>106.04<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>-0.5<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"PPT\">PPT<\/a>&nbsp;&nbsp;&nbsp; PERPETUAL LIMITED<\/h2>\n<p><strong>Wealth Management &amp; Investments &#8211; Overnight Price: $41.52 <\/strong><\/p>\n<p>Jarden rates ((PPT)) as Downgrade to Underweight from Overweight (2) &#8211;<\/p>\n<p>It is Jarden&#039;s view that Perpetual&#039;s sizeable cost growth guidance and continued Barrow Hanley outflows in FY22 are likely to hamper short-term earnings.<\/p>\n<p>The company is guiding to cost growth of 17-21%, above Jarden&#039;s 13% growth forecast, given higher-than-expected distributed team spend.&nbsp;<\/p>\n<p>Additionally, Jarden estimates Barrow Hanley will experience outflows of -9% in the next year. Jarden updates earnings per share forecasts by -21%, -8% and 4% through to FY24.&nbsp;<\/p>\n<p>Despite the FY22 outlook, Perpetual&#039;s profit after tax for FY21 of $124m&nbsp;was in line with Jarden&#039;s&nbsp;forecast.&nbsp;<\/p>\n<p>The rating is downgraded to Underweight from Overweight and the target price decreases to $36.75 from $39.15.<\/p>\n<p>This report was published on August 20, 2021.<\/p>\n<p>Target price is <strong>$36.75<\/strong> Current Price is <strong>$41.52 <\/strong> Difference: <strong>minus $4.77<\/strong> (current price is over target).<br \/>If <strong>PPT<\/strong> meets the Jarden target it will return approximately <strong>minus 11%<\/strong> (excluding dividends, fees and charges &#8211; negative figures indicate an expected loss).<br \/>Current consensus price target is <strong>$40.14<\/strong>, suggesting downside of <strong>-1.5%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Jarden forecasts a full year <strong>FY22<\/strong> dividend of <strong>183.00<\/strong> cents and EPS of <strong>214.20<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>4.41%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>19.38<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>244.7<\/strong>, implying annual growth of <strong>81.3%<\/strong>.<br \/>Current consensus DPS estimate is <strong>195.6<\/strong>, implying a prospective dividend yield of <strong>4.8%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>16.6<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Jarden forecasts a full year <strong>FY23<\/strong> dividend of <strong>197.70<\/strong> cents and EPS of <strong>231.40<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>4.76%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>17.94<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>264.5<\/strong>, implying annual growth of <strong>8.1%<\/strong>.<br \/>Current consensus DPS estimate is <strong>211.8<\/strong>, implying a prospective dividend yield of <strong>5.2%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>15.4<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>0.5<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"PSQ\">PSQ<\/a>&nbsp;&nbsp;&nbsp; PACIFIC SMILES GROUP LIMITED<\/h2>\n<p><strong>Healthcare services &#8211; Overnight Price: $2.51 <\/strong><\/p>\n<p>Wilsons rates ((PSQ)) as Overweight (1) &#8211;<\/p>\n<p>Pacific Smiles Group reported solid FY21 results, including a 73% increase in net profit after tax to $14m, but Wilsons notes the intensity and longevity of the delta outbreak in New South Wales in likely to impact profitability in the first half of FY22.<\/p>\n<p>While previous lockdowns would suggest quick volume returns when restrictions ease, given the absence of JobKeeper&nbsp;this year, the broker decreases profitability forecasts.&nbsp;<\/p>\n<p>Wilsons notes its -11% earnings per share forecast decrease for FY23&nbsp;could be conservative as it is yet to reflect the company&#039;s accelerated rollout plans.&nbsp;<\/p>\n<p>The Overweight rating is retained and the target price decreases to $2.75 from $2.95.&nbsp;<\/p>\n<p>This report was published on August 19, 2021.<\/p>\n<p>Target price is <strong>$2.75<\/strong> Current Price is <strong>$2.51 <\/strong> Difference: <strong>$0.24<\/strong><br \/>If <strong>PSQ<\/strong> meets the Wilsons target it will return approximately <strong> 10%<\/strong> (excluding dividends, fees and charges).<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Wilsons forecasts a full year <strong>FY22<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>2.50<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>100.40<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Wilsons forecasts a full year <strong>FY23<\/strong> dividend of <strong>6.30<\/strong> cents and EPS of <strong>9.00<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>2.51%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>27.89<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>1.0<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"SGF\">SGF<\/a>&nbsp;&nbsp;&nbsp; SG FLEET GROUP LIMITED<\/h2>\n<p><strong>Vehicle Leasing &amp; Salary Packaging &#8211; Overnight Price: $2.70 <\/strong><\/p>\n<p>Canaccord Genuity rates ((SGF)) as Initiation of coverage with Buy (1) &#8211;<\/p>\n<p>Due to what Canaccord Genuity regards as a stable revenue profile, broad technology, and mobility offerings, supportive market conditions and undemanding valuation, the broker<strong>&nbsp;<\/strong>has initiated coverage of SG Fleet Group with a Buy&nbsp;recommendation and a $3.72 price target.<\/p>\n<p>Canaccord&nbsp;is drawn to the benefits flowing from LeasePlan plus what the broker deems to be strengthening operating conditions for fleet managers, supported by a sharp recovery in Australian new car sales and the group confirming strong growth in its leads and order pipeline.<\/p>\n<p>This report was issued on August 19, 2021.<\/p>\n<p>Target price is <strong>$3.72<\/strong> Current Price is <strong>$2.70 <\/strong> Difference: <strong>$1.02<\/strong><br \/>If <strong>SGF<\/strong> meets the Canaccord Genuity target it will return approximately <strong> 38%<\/strong> (excluding dividends, fees and charges).<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Canaccord Genuity forecasts a full year <strong>FY22<\/strong> dividend of <strong>14.00<\/strong> cents and EPS of <strong>23.00<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>5.19%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>11.74<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Canaccord Genuity forecasts a full year <strong>FY23<\/strong> dividend of <strong>15.00<\/strong> cents and EPS of <strong>26.00<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>5.56%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>10.38<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>0.5<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"SUL\">SUL<\/a>&nbsp;&nbsp;&nbsp; SUPER RETAIL GROUP LIMITED<\/h2>\n<p><strong>Automobiles &amp; Components &#8211; Overnight Price: $11.99 <\/strong><\/p>\n<p>Bell Potter rates ((SUL)) as Hold (3) &#8211;<\/p>\n<p>Super Retail Group has reported a strong FY21 result, with underlying earnings up 80% year-on-year. Bell Potter notes the result was driven by growth in like-for-like sales, gross margin expansion and operating expenditure leverage.&nbsp;<\/p>\n<p>The broker further highlighted Super Retail is well positioned to navigate lockdowns, with a strong net cash position of $242.3m at the end of FY21.<\/p>\n<p>Following the modest beat in results, Bell Potter increases earnings per share forecasts by 1.7%, 0.8% and 0.3% through to FY24.<\/p>\n<p>The Hold rating is retained and the target price increases to $12.35 from $12.05.<\/p>\n<p>This report was published&nbsp;on August 19, 2021.<\/p>\n<p>Target price is <strong>$12.35<\/strong> Current Price is <strong>$11.99 <\/strong> Difference: <strong>$0.36<\/strong><br \/>If <strong>SUL<\/strong> meets the Bell Potter target it will return approximately <strong> 3%<\/strong> (excluding dividends, fees and charges).<br \/>Current consensus price target is <strong>$13.76<\/strong>, suggesting upside of <strong>11.8%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY22<\/strong> dividend of <strong>51.60<\/strong> cents and EPS of <strong>86.00<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>4.30%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>13.94<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>91.3<\/strong>, implying annual growth of <strong>-31.6%<\/strong>.<br \/>Current consensus DPS estimate is <strong>57.9<\/strong>, implying a prospective dividend yield of <strong>4.7%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>13.5<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY23<\/strong> dividend of <strong>48.80<\/strong> cents and EPS of <strong>81.40<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>4.07%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>14.73<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>90.8<\/strong>, implying annual growth of <strong>-0.5%<\/strong>.<br \/>Current consensus DPS estimate is <strong>55.6<\/strong>, implying a prospective dividend yield of <strong>4.5%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>13.5<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>0.5<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"SXL\">SXL<\/a>&nbsp;&nbsp;&nbsp; SOUTHERN CROSS MEDIA GROUP LIMITED<\/h2>\n<p><strong>Print, Radio &amp; TV &#8211; Overnight Price: $2.13 <\/strong><\/p>\n<p>Canaccord Genuity rates ((SXL)) as Buy (1) &#8211;<\/p>\n<p>While Southern Cross Media Group delivered a&nbsp;beat on earnings, lower net debt, strongly growing digital audio revenues,&nbsp;and the return of a strong dividend in&nbsp;FY21,&nbsp;Canaccord Genuity&nbsp;is mindful of tougher competition&nbsp;through the balance of FY22.<\/p>\n<p>The broker notes there are set to be numerous moving parts between the group&#039;s FY21 and FY22, notably the lower revenue from the regional TV affiliate switch, offset by the lower payaway.<\/p>\n<p>Canaccord expects around $40m of non-repeat cost benefits to&nbsp;roll out of non-revenue related costs, together with investment in Digital Audio, CPI increases, and reversals of other temporary costs. The broker estimate overheads will increase from $245m in FY21 to $306m in FY22.<\/p>\n<p>Overall, the broker&#039;s&nbsp;revenue and total costs forecasts come down by -11% each, resulting in an -8% lower FY22 earnings&nbsp;forecast, with similar changes in FY23.<\/p>\n<p>The Buy rating is unchanged and the price target decreases to $2.50 from $2.70.<\/p>\n<p>This report was published on August 19, 2021.<\/p>\n<p>Target price is <strong>$2.50<\/strong> Current Price is <strong>$2.13 <\/strong> Difference: <strong>$0.37<\/strong><br \/>If <strong>SXL<\/strong> meets the Canaccord Genuity target it will return approximately <strong> 17%<\/strong> (excluding dividends, fees and charges).<br \/>Current consensus price target is <strong>$2.07<\/strong>, suggesting downside of <strong>-1.6%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Canaccord Genuity forecasts a full year <strong>FY22<\/strong> dividend of <strong>12.00<\/strong> cents and EPS of <strong>15.00<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>5.63%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>14.20<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>18.0<\/strong>, implying annual growth of <strong>-1.1%<\/strong>.<br \/>Current consensus DPS estimate is <strong>8.7<\/strong>, implying a prospective dividend yield of <strong>4.1%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>11.7<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Canaccord Genuity forecasts a full year <strong>FY23<\/strong> dividend of <strong>14.00<\/strong> cents and EPS of <strong>19.00<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>6.57%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>11.21<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>18.2<\/strong>, implying annual growth of <strong>1.1%<\/strong>.<br \/>Current consensus DPS estimate is <strong>15.3<\/strong>, implying a prospective dividend yield of <strong>7.3%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>11.5<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>0.3<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"SXY\">SXY<\/a>&nbsp;&nbsp;&nbsp; SENEX ENERGY LIMITED<\/h2>\n<p><strong>Crude Oil &#8211; Overnight Price: $3.39 <\/strong><\/p>\n<p>Bell Potter rates ((SXY)) as Buy (1) &#8211;<\/p>\n<p>Following&nbsp;the&nbsp;FY21 result, broadly in line with Bell Potter estimates,&nbsp;Senex Energy is guiding to further strong growth in FY22.<\/p>\n<p>Production guidance is up 27%, while&nbsp;earnings guidance&nbsp;of $75-85m, up 47%, is&nbsp;weaker than&nbsp;Bell Potter&nbsp;had previously expected, as the outlook for&nbsp;realised prices proved different.<\/p>\n<p>Buy rating is unchanged and the target price is lowered to $3.70 from&nbsp;$3.75.<\/p>\n<p>This report was published on July 21, 2021.<\/p>\n<p>Target price is <strong>$3.70<\/strong> Current Price is <strong>$3.39 <\/strong> Difference: <strong>$0.31<\/strong><br \/>If <strong>SXY<\/strong> meets the Bell Potter target it will return approximately <strong> 9%<\/strong> (excluding dividends, fees and charges).<br \/>Current consensus price target is <strong>$3.79<\/strong>, suggesting upside of <strong>12.1%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY22<\/strong> dividend of <strong>8.00<\/strong> cents and EPS of <strong>23.80<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>2.36%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>14.24<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>19.5<\/strong>, implying annual growth of <strong>-45.7%<\/strong>.<br \/>Current consensus DPS estimate is <strong>9.2<\/strong>, implying a prospective dividend yield of <strong>2.7%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>17.3<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY23<\/strong> dividend of <strong>15.00<\/strong> cents and EPS of <strong>40.40<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>4.42%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>8.39<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>27.7<\/strong>, implying annual growth of <strong>42.1%<\/strong>.<br \/>Current consensus DPS estimate is <strong>12.0<\/strong>, implying a prospective dividend yield of <strong>3.6%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>12.2<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>0.7<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<hr \/>\n<p>Jarden rates ((SXY)) as Buy (1) &#8211;<\/p>\n<p>Senex Energy has reported underlying earnings for FY21 of $57m and profit after tax of $5.4m. Jarden notes the final dividend of 5 cents per share was surprisingly strong.<\/p>\n<p>Looking ahead, the company is guiding to production of 21-23 petajoules&nbsp;and underlying earnings of $75-85m for FY22, both in line with the broker&#039;s expectations.<\/p>\n<p>Jarden notes free cash flow guidance of $50-60m is now at the upper end of previous guidance despite oil hedging losses in the year, which is largely attributed to sustained capital expenditure guidance now -50% below prior expectations.&nbsp;<\/p>\n<p>It is Jarden&#039;s view that Senex Energy has a clear path to doubling current production to 36 petajoules per annum by the end of FY23, and considers the company a relatively low-risk investment.&nbsp;<\/p>\n<p>The Buy rating and target price of $4.15 are retained.&nbsp;<\/p>\n<p>This report was published on August 19, 2021.<\/p>\n<p>Target price is <strong>$4.15<\/strong> Current Price is <strong>$3.39 <\/strong> Difference: <strong>$0.76<\/strong><br \/>If <strong>SXY<\/strong> meets the Jarden target it will return approximately <strong> 22%<\/strong> (excluding dividends, fees and charges).<br \/>Current consensus price target is <strong>$3.79<\/strong>, suggesting upside of <strong>12.1%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Jarden forecasts a full year <strong>FY22<\/strong> dividend of <strong>8.00<\/strong> cents and EPS of <strong>15.60<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>2.36%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>21.73<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>19.5<\/strong>, implying annual growth of <strong>-45.7%<\/strong>.<br \/>Current consensus DPS estimate is <strong>9.2<\/strong>, implying a prospective dividend yield of <strong>2.7%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>17.3<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Jarden forecasts a full year <strong>FY23<\/strong> dividend of <strong>8.50<\/strong> cents and EPS of <strong>19.00<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>2.51%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>17.84<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>27.7<\/strong>, implying annual growth of <strong>42.1%<\/strong>.<br \/>Current consensus DPS estimate is <strong>12.0<\/strong>, implying a prospective dividend yield of <strong>3.6%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>12.2<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>0.7<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"TAH\">TAH<\/a>&nbsp;&nbsp;&nbsp; TABCORP HOLDINGS LIMITED<\/h2>\n<p><strong>Gaming &#8211; Overnight Price: $4.85 <\/strong><\/p>\n<p>Goldman Sachs rates ((TAH)) as Buy (1) &#8211;<\/p>\n<p>While&nbsp;current lockdowns are a headwind for Tabcorp Holdings&#039; retail wagering and gaming services business, Goldman Sachs notes&nbsp;this is partly offset by tailwinds for its digital Lotteries and wagering businesses.<\/p>\n<p>The broker expects the company&#039;s -$20-25m&nbsp;in earnings savings from its optimisation program in FY22 to cushion&nbsp;lockdown headwinds.<\/p>\n<p>Goldman Sachs believes management comments underpin the broker&#039;s&nbsp;thesis that OzLotto game changes will likely be approved towards the back end of FY22, which the broker expects to provide a meaningful tailwind for FY23 earnings.<\/p>\n<p>Goldman Sachs makes&nbsp;minor earnings&nbsp;changes across FY22-23&nbsp;and introduces FY24 estimates.&nbsp;<\/p>\n<p>Buy rating maintained and target increases to $5.89 from $5.83.<\/p>\n<p>This report was issued August 18, 2021.<\/p>\n<p>Target price is <strong>$5.89<\/strong> Current Price is <strong>$4.85 <\/strong> Difference: <strong>$1.04<\/strong><br \/>If <strong>TAH<\/strong> meets the Goldman Sachs target it will return approximately <strong> 21%<\/strong> (excluding dividends, fees and charges).<br \/>Current consensus price target is <strong>$5.49<\/strong>, suggesting upside of <strong>12.8%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Goldman Sachs forecasts a full year <strong>FY22<\/strong> dividend of <strong>17.00<\/strong> cents and EPS of <strong>21.00<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>3.51%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>23.10<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>18.1<\/strong>, implying annual growth of <strong>46.9%<\/strong>.<br \/>Current consensus DPS estimate is <strong>14.9<\/strong>, implying a prospective dividend yield of <strong>3.1%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>26.9<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Goldman Sachs forecasts a full year <strong>FY23<\/strong> dividend of <strong>19.00<\/strong> cents and EPS of <strong>23.00<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>3.92%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>21.09<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>21.1<\/strong>, implying annual growth of <strong>16.6%<\/strong>.<br \/>Current consensus DPS estimate is <strong>17.1<\/strong>, implying a prospective dividend yield of <strong>3.5%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>23.1<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>0.8<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"TLX\">TLX<\/a>&nbsp;&nbsp;&nbsp; TELIX PHARMACEUTICALS LIMITED<\/h2>\n<p><strong>Pharmaceuticals &amp; Biotech\/Lifesciences &#8211; Overnight Price: $6.87 <\/strong><\/p>\n<p>Bell Potter rates ((TLX)) as Downgrade to Hold from Buy (3) &#8211;<\/p>\n<p>While there was no&nbsp;significant trading update accompanying&nbsp;Telix Pharmaceuticals&#039; first half FY21 earnings announcement, Bell Potter suspects all eyes are now on FDA approval of Illuccix for the imaging of recurrent prostate cancer which is due in September.<\/p>\n<p>The broker notes a further 16 countries are also likely to approve the drug this calendar year.<\/p>\n<p>The company has notional cash of $61m which the broker believes is more than sufficient to support ongoing operations.&nbsp;<\/p>\n<p>Following the recent share price movement, Bell Potter downgrades Telix Pharmaceuticals to Hold from Buy and the target price is unchanged at $8.00.<\/p>\n<p>This report was issued August 20, 2021.<\/p>\n<p>Target price is <strong>$8.00<\/strong> Current Price is <strong>$6.87 <\/strong> Difference: <strong>$1.13<\/strong><br \/>If <strong>TLX<\/strong> meets the Bell Potter target it will return approximately <strong> 16%<\/strong> (excluding dividends, fees and charges).<br \/>The company&#039;s fiscal year ends in December.<\/p>\n<p><strong>Forecast for FY21:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY21<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>minus 16.90<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>minus 40.65<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Bell Potter forecasts a full year <strong>FY22<\/strong> dividend of <strong>0.00<\/strong> cents and EPS of <strong>minus 5.70<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>minus 120.53<\/strong>.<\/p>\n<\/blockquote>\n<p>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"TPG\">TPG<\/a>&nbsp;&nbsp;&nbsp; TPG TELECOM LIMITED<\/h2>\n<p><strong>Telecommunication &#8211; Overnight Price: $6.48 <\/strong><\/p>\n<p>Goldman Sachs rates ((TPG)) as Neutral (3) &#8211;<\/p>\n<p>Following TPG Telecom&#039;s first-half FY21 result, highlighted by a disappointing revenue trend, but including a cost control-driven earnings beat, the company provided no guidance. Management did re-iterate&nbsp;its previous 2021 and&nbsp;2023 synergy targets.<\/p>\n<p>With the intention of maximising shareholder return, the&nbsp;company announced a strategic review of its 1,200 owned mobile sites (towers plus rooftops).<\/p>\n<p>Goldman Sachs notes&nbsp;in the TPG\/Vodafone scheme booklet, Vodafone disclosed ownership of 467 mobile sites. This suggests to the broker that either the 1,200 sites will include TPG 400 small cells, or that there has been significant construction activity since merger completion.<\/p>\n<p>Neutral rating is maintained, and the price target is increased to $6.30 from $6.20.<\/p>\n<p>This report was published on August 20, 2021.&nbsp;<\/p>\n<p>Target price is <strong>$6.30<\/strong> Current Price is <strong>$6.48 <\/strong> Difference: <strong>minus $0.18<\/strong> (current price is over target).<br \/>If <strong>TPG<\/strong> meets the Goldman Sachs target it will return approximately <strong>minus 3%<\/strong> (excluding dividends, fees and charges &#8211; negative figures indicate an expected loss).<br \/>Current consensus price target is <strong>$7.53<\/strong>, suggesting upside of <strong>16.5%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in December.<\/p>\n<p><strong>Forecast for FY21:<\/strong><\/p>\n<blockquote>\n<p>Goldman Sachs forecasts a full year <strong>FY21<\/strong> dividend of <strong>15.00<\/strong> cents and EPS of <strong>24.00<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>2.31%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>27.00<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>14.6<\/strong>, implying annual growth of <strong>-77.2%<\/strong>.<br \/>Current consensus DPS estimate is <strong>12.8<\/strong>, implying a prospective dividend yield of <strong>2.0%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>44.2<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Goldman Sachs forecasts a full year <strong>FY22<\/strong> dividend of <strong>23.00<\/strong> cents and EPS of <strong>28.00<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>3.55%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>23.14<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>19.2<\/strong>, implying annual growth of <strong>31.5%<\/strong>.<br \/>Current consensus DPS estimate is <strong>13.0<\/strong>, implying a prospective dividend yield of <strong>2.0%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>33.6<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>0.7<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"VCX\">VCX<\/a>&nbsp;&nbsp;&nbsp; VICINITY CENTRES<\/h2>\n<p><strong>REITs &#8211; Overnight Price: $1.72 <\/strong><\/p>\n<p>Goldman Sachs rates ((VCX)) as Buy (1) &#8211;<\/p>\n<p>Goldman Sachs&nbsp;believes Vicinity Centres&nbsp;is positioned to weather any further uncertainty related to the prolonged covid&nbsp;impacted environment.<\/p>\n<p>The broker believes this is especially so given its low gearing enables the company to&nbsp;absorb further asset devaluations and fund medium\/long-term large-scale mixed-use developments post-covid.<\/p>\n<p>However, the broker notes the operating environment remains challenging, particularly in NSW &amp; Voictoria where 75%-80% of tenants are not trading.<\/p>\n<p>The company did not provide FY22 earnings guidance due to the uncertainty around the covid delta variant outbreak, but Goldman Sachs notes management&#039;s plans&nbsp;to target a distribution based on an adjusted funds from operations payout ratio of 95%-100%.<\/p>\n<p>The Buy rating is unchanged and the target price is lowered -2% to $1.77.<\/p>\n<p>This report was published on August 18, 2021.&nbsp;<\/p>\n<p>Target price is <strong>$1.77<\/strong> Current Price is <strong>$1.72 <\/strong> Difference: <strong>$0.05<\/strong><br \/>If <strong>VCX<\/strong> meets the Goldman Sachs target it will return approximately <strong> 3%<\/strong> (excluding dividends, fees and charges).<br \/>Current consensus price target is <strong>$1.64<\/strong>, suggesting downside of <strong>-4.6%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in June.<\/p>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Goldman Sachs forecasts a full year <strong>FY22<\/strong> EPS of <strong>12.00<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>14.33<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>9.8<\/strong>, implying annual growth of <strong>N\/A<\/strong>.<br \/>Current consensus DPS estimate is <strong>8.0<\/strong>, implying a prospective dividend yield of <strong>4.7%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>17.6<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY23:<\/strong><\/p>\n<blockquote>\n<p>Goldman Sachs forecasts a full year <strong>FY23<\/strong> EPS of <strong>13.00<\/strong> cents.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>13.23<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>11.7<\/strong>, implying annual growth of <strong>19.4%<\/strong>.<br \/>Current consensus DPS estimate is <strong>9.9<\/strong>, implying a prospective dividend yield of <strong>5.8%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>14.7<\/strong>.<\/p>\n<\/blockquote>\n<p>Market Sentiment: <strong>-0.2<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<h2><a name=\"WPL\">WPL<\/a>&nbsp;&nbsp;&nbsp; WOODSIDE PETROLEUM LIMITED<\/h2>\n<p><strong>NatGas &#8211; Overnight Price: $20.81 <\/strong><\/p>\n<p>Goldman Sachs rates ((WPL)) as No Rating (-1) &#8211;<\/p>\n<p>As highlighted by Goldman Sachs recently, the outlook for Woodside Petroleum&nbsp;is driven by the planned delivery of the Scarborough project with the final investment decision (FID) targeted by the end of 2021 as well as&nbsp;the progress on the proposed merger of the portfolio with BHP Petroleum by second quarter 2022.<\/p>\n<p>Total expenditure guidance is unchanged at -US$2.9-3.2bn, and full-year&nbsp;trading costs including Corpus Christi are expected at -US$1.1-1.3bn.<\/p>\n<p>Management commentary confirmed this implies traded LNG volumes are expected to nearly double in the second half, although it also&nbsp;highlighted the trading increase as opportunistic on market conditions and may not carry forward.<\/p>\n<p>As a result of the higher trading activity, the broker expects 25% of LNG sales volumes to come from trading in 2021, up from 7% in 2020.<\/p>\n<p>Goldman Sachs is currently not rated on Woodside.<\/p>\n<p>This report was published on August 18, 2021.<\/p>\n<p>Current Price is <strong>$20.81<\/strong>. Target price not assessed.<br \/>Current consensus price target is <strong>$25.97<\/strong>, suggesting upside of <strong>26.2%<\/strong>(ex-dividends)<br \/>The company&#039;s fiscal year ends in December.<\/p>\n<p><strong>Forecast for FY21:<\/strong><\/p>\n<blockquote>\n<p>Goldman Sachs forecasts a full year <strong>FY21<\/strong> dividend of <strong>144.99<\/strong> cents and EPS of <strong>180.90<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>6.97%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>11.50<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>169.3<\/strong>, implying annual growth of <strong>N\/A<\/strong>.<br \/>Current consensus DPS estimate is <strong>121.0<\/strong>, implying a prospective dividend yield of <strong>5.9%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>12.2<\/strong>.<\/p>\n<\/blockquote>\n<p><strong>Forecast for FY22:<\/strong><\/p>\n<blockquote>\n<p>Goldman Sachs forecasts a full year <strong>FY22<\/strong> dividend of <strong>211.49<\/strong> cents and EPS of <strong>263.37<\/strong> cents.<br \/>At the last closing share price the estimated dividend yield is <strong>10.16%<\/strong>.<br \/>At the last closing share price the stock&#039;s estimated Price to Earnings Ratio (PER) is <strong>7.90<\/strong>.<\/p>\n<p>How do these forecasts compare to market consensus projections?<\/p>\n<p>Current consensus EPS estimate is <strong>181.8<\/strong>, implying annual growth of <strong>7.4%<\/strong>.<br \/>Current consensus DPS estimate is <strong>115.2<\/strong>, implying a prospective dividend yield of <strong>5.6%<\/strong>.<br \/>Current consensus EPS estimate suggests the PER is <strong>11.3<\/strong>.<\/p>\n<\/blockquote>\n<p>This company reports in <strong>USD<\/strong>. All estimates have been converted into AUD by FNArena at present FX values.<br \/>Market Sentiment: <strong>0.8<\/strong><br \/>All consensus data are updated until yesterday. FNArena&#039;s consensus calculations require a minimum of three sources<\/p>\n<\/p>\n<hr \/>\n<p><strong>Disclaimer:<\/strong><br \/>The content of this information does in no way reflect the opinions of FNArena, or of its journalists. In fact we don&#039;t have any opinion about the stock market, its value, future direction or individual shares. FNArena solely reports about what the main experts in the market note, believe and comment on. By doing so we believe we provide intelligent investors with a valuable tool that helps them in making up their own minds, reading market trends and getting a feel for what is happening beneath the surface. This document is provided for informational purposes only. It does not constitute an offer to sell or a solicitation to buy any security or other financial instrument. FNArena employs very experienced journalists who base their work on information believed to be reliable and accurate, though no guarantee is given that the daily report is accurate or complete. Investors should contact their personal adviser before making any investment decision.<\/p>\n<p><span style=\"color:#444444\"><span style=\"font-family:arial,sans-serif\"><span style=\"font-size:10.0pt\">As part of emerging new trends overseas, The Australian Broker Call *Extra* Edition also includes providers of sponsored research. Readers should bear in mind, sponsored research, while not necessarily of lower quality, has the embedded complication that the company that is the subject of the research has paid for this research. Providers of sponsored research that can potentially be included in this Report are Breakaway Research, Edison Investment Research, Independent Investment Research, NDF Research, Pitt Street Research, and TMT Analytics.<\/span><\/span><\/span><\/p>\n<p><span style=\"color:#444444\"><span style=\"font-family:arial,sans-serif\"><span style=\"font-size:10.0pt\">Decisions about inclusions in this Report are made independently of the providers of stock market research and at full discretion of the team of journalists responsible for content at FNArena. Inclusion does not equal endorsement, in any way, shape or form. This Report is provided for informational purposes only.<\/span><\/span><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Extra Edition of the Broker Call Report<\/p>\n","protected":false},"author":3,"featured_media":96537,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[84],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/posts\/96535"}],"collection":[{"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/comments?post=96535"}],"version-history":[{"count":0,"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/posts\/96535\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/media\/96537"}],"wp:attachment":[{"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/media?parent=96535"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/categories?post=96535"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/staging.fnarena.com\/index.php\/wp-json\/wp\/v2\/tags?post=96535"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}